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Focused ultrasound (FUS) is a promising thermal treatment modality which deposits 
heat noninvasively in a confined tissue volume to treat localized diseased tissue or 
malignancy through hyperthermia or high temperature ablation. FUS compatible guiding and 
monitoring systems to provide real-time information on tissue temperature and/or status 
(e.g., native or necrotized) are important to ensure safe and effective treatment outcome; 
however, current development of such systems are restricted to ultrasound and magnetic 
resonance imaging (MRI). The work described in this dissertation represents efforts not only 
to explore new tools to evaluate current monitoring techniques but also to develop new FUS 
monitoring modalities. In the first study, a new evaluation platform for ultrasound 
thermometry using infrared (IR) thermography was developed and demonstrated using 
phantoms subjected to FUS heating, providing a fast calibration and validation tool with 
spatiotemporal temperature information unavailable with traditional thermocouple 
measurements. In the second study, IR thermography was investigated as a new tool for high 
temperature FUS ablation monitoring. The spatiotemporal temperature characteristics in 
correspondence to lesion formation and bubble activities were identified using simultaneous 
IR and bright-field imaging. Tissue-specific thermal damage threshold, which is critical for 
accurate estimation of tissue status based on temperature time history, was also obtained 
using the same system. In the final study, we developed a novel dual-wavelength 
photoacoustic (PA) sensing technique for monitoring tissue status during thermal treatments, 
which is capable of separating the two effects from temperature rise and changes in optical 
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properties due to tissue alteration. Experimental validations of the theoretical derivation were 
carried out on ex-vivo cardiac tissue using water-bath heating on lesions generated by FUS. 
Future directions of research include in-vivo technique demonstration where effects such as 
blood perfusion on FUS heating need to be considered. When FUS operates in the non-
ablative regime without causing irreversible changes in tissue, treatment monitoring 
techniques investigated in this study also have the potential to be translated into diagnostic 
tools. 





1.1 Thermal therapy 
Treatment modalities for treating localized diseased tissue or malignancy have 
evolved from invasive surgeries to minimally invasive and further to noninvasive techniques 
over the past few decades.1,2 Open surgery imposes great risk on patients with its high 
morbidity and mortality rate and the recovery time is often lengthy. Less invasive 
laparoscopic surgery has become more adopted with lower complications and less pain and 
scarring compared to open surgery,3,4 but with concerns including port site metastases due to 
surgical operation.5 Many of the other minimally invasive techniques are based on thermal 
therapy, which has been proven to be effective in treating benign and malignant diseases.  
Thermal therapy can be classified into two categories. Hyperthermia, in which tissue 
temperature is elevated from normal body temperature, 37 °C, to 41 – 45 °C, is often used for 
cancer treatment in conjunction with radiation therapy and chemotherapy.6-9 The elevated 
temperature also allows for controlled drug release using thermosensitive agents loaded with 
drugs.10 Another type of thermal therapy is high temperature ablation which can destruct 
diseased tissue through the induction of coagulative necrosis.11 Common heat sources to 
induce hyperthermia and thermal ablation include radiofrequency, microwave, laser, and 
focused ultrasound (FUS). Among all types of heat source, FUS is the truly noninvasive 
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treatment modality which is capable of inducing localized heating in deep tissue from 
thermoviscous absorption of ultrasound energy.1,12-13  
1.1.1 Hyperthermia 
Whole-body hyperthermia, which heats up not only the target tissue but also the 
normal tissue, is often associated with systemic or local side-effects.14 Therefore, recent 
developments in hyperthermia have been focused on localized or targeted hyperthermia 
where heating is restricted to a confined tissue volume (e.g., tumor site).  
There are various aspects of hyperthermia in its interaction with tissue/cell to achieve 
therapeutic effects. For example, elevated temperature increases blood flow, resulting in a 
higher concentration of drugs in the region subjected to hyperthermia, and therefore yields a 
higher drug uptake at the target site.14 It was also found that some gene regulations can be 
modulated by heat (e.g., heat-shock proteins).15 Hyperthermia can also be applied to trigger 
the release of chemotherapeutic drugs loaded in thermosensitive liposomes, which further 
reduces the drug exposure to normal tissue.16-18 Other bio-compatible materials on the micron 
or nanometer scale have also been developed to work with hyperthermia to improve 
treatment efficacy. These materials can be injected into the patient’s circulatory system just 
like the liposomes to enhance the heating efficiency with site specificity. For example, metal 
nanoparticles capable of converting electromagnetic energy into heat have been developed 
with cancer-specific molecules to bind to cancer cells.15,19 
FUS hyperthermia has been used in adjunct to radiotherapy and showed improved 
treatment outcome compared to using the radiotherapy alone.20-22 An active research field 
using FUS hyperthermia is in enhanced targeted drug delivery to tumors using 
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thermosensitive liposomes.10,16,23 Various strategies for optimizing FUS exposures for 
hyperthermia applications have also been investigated.24,25 
1.1.2 High temperature ablation 
Delivery of lethal energies to the diseased tissue can lead to irreversible damage. 
Except for cryoablation which induces cell death by freezing, other minimally invasive 
ablative modalities operate in the higher temperature range (> 50 °C) above the threshold for 
tissue necrosis/coagulation. Radiofrequency (RF) ablation is widely used, in which high-
frequency AC current is delivered to the target site through a needle electric probe or catheter 
where the electrical energy is converted into heat.1,26  Because the tip of the probe needs to be 
in contact with the tissue, RF ablation is delivered through open or laparoscopic surgery or 
percutaneously. Another type of ablation uses laser (photothermal) in which laser fiber is 
guided by needles to the target site to deliver light. It is often used with nanomaterials which 
have strong optical absorption in the near-infrared region.27,28  
FUS, unlike these other methods, is the only truly noninvasive modality for heat 
deposition. The use of FUS at higher intensities to raise tissue temperatures sufficiently high 
to generate thermal damage is usually termed high-intensity focused ultrasound ablation, or 
simply as HIFU ablation. Its clinical application include cancer treatments (e.g., prostate,29,30 
liver,31,32 kidney,32-34 bone,35 and brain36), uterine fibroid treatments,37,38 and 
neurosurgeries.39 For HIFU treatments of biological tissues, it is important to have 
monitoring techniques to measure tissue change (e.g., from native to coagulated) for 




1.2 Current FUS monitoring techniques 
1.2.1 Tissue temperature and tissue status 
For successful FUS thermal therapy, the heating process has to be closely monitored. 
Two aspects can be monitored: tissue temperature and tissue status. Temperature 
measurement is critical for both hyperthermia and HIFU ablation. In FUS-induced 
hyperthermia, the spatiotemporal temperature evolution needs to be monitored to ensure 
sufficient temperature increase to trigger desired events (e.g., drug release), while 
maintaining the temperature below a certain threshold so as not to cause irreversible damage 
to the cells.40 In HIFU ablation, the temperature time history can be used to calculate the 
thermal dose, which is then used to predict tissue necrosis/coagulation. The temperature 
distribution has to be carefully controlled so that thermal damage to the tissue only occurs in 
the target treatment volume and not the surrounding normal tissue. 
Tissue status is the other parameter to monitor and applies specifically for HIFU 
ablation where the tissue changes from its native state to necrotized or coagulated state 
during treatment. These changes are reflected in changes in tissue properties such as optical, 
acoustic, mechanical, and thermal properties. For both temperature measurement and tissue 
characterization, the two most widely investigated noninvasive imaging modalities for real-
time FUS monitoring are magnetic resonance imaging (MRI) and ultrasound imaging. 
1.2.2 Magnetic resonance imaging in FUS monitoring 
MRI is capable of estimating temperature increases with sensitivity within a few 
degrees41,42 based on temperature-sensitive MR parameters such as T1 and T2 relaxation time, 
proton resonance frequency (PRF), and proton diffusion coefficient (D).41,43 MRI-guided 
focused ultrasound (MRIgFUS) has been used clinically to treat uterine fibroid and breast 
5 
 
tumors and noninvasively estimate tissue temperature44-46 and are currently the only FDA-
approved clinical HIFU systems. For tissue characterization, post-treatment MRI also 
provides good contrast in delineating tissue types and HIFU lesions with millimeter spatial 
resolution.44,47 
However, there are several disadvantages of MRI. For MRIgFUS ablation in liver and 
kidney,48-50 its unreliable temperature measurement in fat and susceptibility to artifacts 
induced by organ displacements still remains a challenge.43 Furthermore, the acquisition 
duration required by MRI (few seconds/frame)51 may limit its use in treatments using short 
FUS pulses with rapid tissue heating41 or result in extended treatment time.52 The average 
treatment time using MRIgFUS is between 1 – 4 hours with the total hours in the scanner 
being longer.45,53 The treatment devices are also required to be made MR-compatible. 
Moreover, the high cost of MRI scanners, the claustrophobia and discomfort for some 
patients in closed-bore systems, and the lack of portability of MRI systems may further 
restrict the widespread use of the technology for FUS therapy.1 
1.2.3 Ultrasound imaging in FUS monitoring 
In contrast, ultrasound is non-ionizing and the imaging systems have high portability 
and are at a lower cost. Ultrasound systems are also inherently compatible to various types of 
thermal treatment devices. Dual-mode transducers for both imaging and thermal therapy have 
also been designed with the main advantage being implicit registration of the targeted 
region.54 Conventional diagnostic ultrasound imaging with gray-scale representation 
(B-mode imaging) is frequently applied to monitoring HIFU ablation. However, in the 
absence of the occurrence of bubbles at high ultrasound pressure level and/or boiling 
temperature, the low acoustic contrast between coagulated and native tissue itself is not 
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always sufficient. This urges researchers to derive various parameters to improve the 
visualization and detection of lesion formation,55 including ultrasound attenuation and 
backscatter,56,57 spectral parameters,58,59 thermal strain60,61 or stiffness (e.g., using acoustic 
radiation force imaging (ARFI)62,63). For temperature estimation, temperature-dependent 
changes in the ultrasound backscattered signals are used. A variety of techniques have been 
explored, including methods based on echo time shifts,64-70 changes in backscatter 
energy,71-73 and spectral parameters.74 For accurate temperature estimation, all methods 
require calibrations in advance as the temperature dependency of these parameters are tissue 
type specific. These methods also need to account for artifacts from organ/tissue movement. 
Furthermore, as a result of problems associated with the rapid and large range of temperature 
variations in HIFU ablation and disruption by cavity formation,75,76 ultrasound thermometry 
has been mostly used in the hyperthermia temperature range. 
1.3 Organization of this dissertation 
Motivated by the limited imaging techniques developed for FUS monitoring, in this 
dissertation, we aim to explore new tools to better evaluate current monitoring techniques 
and also develop new imaging methods. 
Ultrasound imaging, although has shown good capability to estimate temperature in 
the hyperthermia regime, requires calibration for different tissue types undergoing FUS 
heating. To calibrate tissue-specific properties and also to verify the design of signal 
processing algorithm, independent temperature measurement is always required. Evaluation 
of ultrasound thermometry is usually done using thermocouples inserted at discrete locations. 
In Chapter 2, infrared (IR) thermography is introduced as a new tool to evaluate ultrasound 
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thermometry with high spatial and high temporal temperature measurements unavailable with 
other tools. 
As we investigate into the higher temperature range reached in HIFU ablation, the 
limited temperature estimation range of ultrasound imaging and the high cost of MRI 
systems urge us to search for alternative imaging tools. At the same time, there is also a need 
to establish a better understanding of the correlation between temperature and HIFU-induced 
events (e.g., tissue necrosis/coagulation and bubble activities). In Chapter 3, IR 
thermography was further used to measure the spatiotemporal temperature on a tissue surface 
during HIFU ablation, and the occurrences of lesion and bubble formation were identified to 
have strong correlations with several temperature-derived parameters. A method to 
experimentally measure the thermal damage threshold for any tissue type is also presented. 
To further explore new imaging methods for FUS monitoring, Chapter 4 describes a 
dual-wavelength photoacoustic (PA) sensing/imaging technique capable of monitoring tissue 
status independent of temperature changes. Compared to IR thermography, PA imaging 
allows a deeper imaging penetration depth. Typical PA imaging methods investigated for 
thermal treatment monitoring exhibit difficulties in identifying tissue coagulation because PA 
signal intensity is both temperature and tissue status dependent. Our technique, however, 
derives a parameter representative of the tissue status only, which enables more robust 
monitoring of thermal ablation. The technique was verified with ex-vivo tissue experiments. 
Finally, Chapter 5 concludes this work and presents future directions, including 
applying the techniques to tissue volume more deeply beneath the tissue subsurface and to 
in-vivo conditions. New applications inspired by the current study will also be discussed. 
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Evaluation of ultrasound thermometry during focused ultrasound heating 
using infrared thermography 
Successful ultrasound temperature estimation relies on 1) accurate calibration 
between changes in ultrasound backscattered signal and temperature increase and 2) 
validation of signal processing methods. However, traditional temperature measurements 
using thermocouples lack spatial information and calibration done using water-bath heating 
is time-consuming. In this chapter, we proposed to use non-contact infrared (IR) 
thermography with high spatial and temporal resolution to facilitate fast calibration and 
validation of ultrasound thermometry methods. To demonstrate the new evaluation platform, 
experiments were performed with simultaneous acquisition of two dimensional (2D) 
ultrasound backscattered signal (B-mode imaging) and IR temperature measurement on the 
surface plane of a phantom subjected to focused ultrasound (FUS) heating, with an 
investigated temperature ranged from 20 °C to 35 °C. Although in this study FUS was 
applied as the heat source and ultrasound processing methods using echo time shifts was used, 
the developed platform using IR thermography can also be applied to developing ultrasound 






For accurate temperature estimation using ultrasound imaging, all methods require 
calibrations in advance as the temperature dependency of the parameters used 
(e.g., backscatter energy, speed of sound) are all tissue type specific. The calibrations are 
typically performed either with uniform heating in water-bath1-4 or with thermocouples 
inserted at multiple discrete locations in the specimen within the field of view of ultrasound 
imaging.5 Water-bath heating requires a longer time for the specimen to reach a uniform 
temperature distribution (e.g., for a 20 °C temperature range, measurements can take several 
hours1). This method is inefficient if a large calibration database for all different tissue types 
is needed. Thermocouples, besides being invasive, disrupt energy propagation during thermal 
heating and the viscous heating and thermal conduction by thermocouples themselves may 
introduce error in measurements, which are most significant in FUS applications.6-9 
In ultrasound thermometry, signal processing methods are also critical as their design 
and implementation greatly affect the accuracy of temperature estimation. Spatial resolution 
is particularly important for thermal therapies targeted at a small treatment volume where the 
induced temperature gradient is steep. However, validation done using thermocouples can 
only evaluate temperature estimations at sparse locations1,2 and is insufficient for optimal 
design of algorithms. Therefore to develop robust ultrasound thermometry methods and to 
investigate their individual performances and limitations, a new evaluation platform for rapid 





Infrared (IR) thermography, although limited to surface measurements, can obtain 
accurate measurements of temperature changes as a function of space and time directly 
without contact. The advantages also include easy implementation, high temporal (> 100 Hz) 
and spatial resolution (< 100 µm). It typically uses the mid-IR (3 – 5 μm) and long-IR 
(8 – 12 μm) spectrum which have sufficient sensitivity for thermal imaging.10 IR 
thermography has been used for diagnosis and treatment monitoring, as demonstrated by 
medical applications such as oncology (breast cancer, skin diseases), skin burns, vascular 
disorders, surgery, tissue viability, sports medicine, and mass screening.10-14 
For FUS-related studies, IR thermography has been used to visualize the locations 
and extent of heat deposition with various target geometries and/or using different designs of 
FUS transducers.15-17 It has also been proposed as a new technique to calibrate transducers 
faster than traditional hydrophone field scans.18,19 It has also been applied to record 
temperature profiles during FUS exposures to evaluate and optimize ultrasound 
parameters.20,21 However, IR thermography has not been applied to the development of 
ultrasound thermometry. 
Our goal for this study is to investigate the feasibility of IR thermography in 
calibrating and evaluating ultrasound thermometry during FUS heating with spatiotemporal 
temperature information unavailable with traditional thermocouple measurements. We 
conducted experiments using two types of phantom, tissue-mimicking and fat-mimicking, to 
investigate their differences in changes in the speed of sound as a function of temperature. 
Simultaneous IR thermography and B-mode ultrasound imaging were used to measure the 
spatiotemporal temperature and ultrasound backscattered signal on the same surface plane of 
the phantoms before, during, and after FUS exposures. A simple echo time shifts method 
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using cross-correlation speckle tracking was chosen for ultrasound thermometry due to its 
wide use. The ultrasound echo time shifts and IR measured temperature were first used for 
material-dependent calibration for each phantom type. Then the calibration results were used 
for ultrasound temperature estimation and the spatiotemporal error was determined by 
comparing with the IR measurement. 
2.2 Materials and methods 
2.2.1 Theory: ultrasound echo time shifts 
When neglecting the thermal expansion effect in the specimen, the time of arrival τ of 
the ultrasound backscattered signal from axial depth y is expressed as 







= ∫ , where c(θ(ξ)) is the speed of sound at depth ξ with temperature θ(ξ). 
In the case of FUS heating, if isotropic free thermal expansion in the specimen is considered, 
the specimen will expand in both directions outward from the center of the heating zone. To 
derive τ from an ultrasound scatterer subjected to FUS heating, the ultrasound beam path can 
be divided into two segments as shown in Fig. 2.1: the first segment is the temperature 
constant zone from the transducer surface (y = 0) to y0 where no temperature changes occur, 
and the second segment is the heating zone from y ≥ y0 with temperature changes δθ(ξ) at 
each depth ξ. For an ultrasound scatterer at depth y before heating, the baseline time of 











τ ξ= + ∫ , (2.1) 
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where c0 is the speed of sound at baseline temperature θ0, and y0 can be further expressed 





y y dξ= − ∫ . After heating, the scatterer 
shifts to depth y′ with a time of arrival τ(y′) now being  










′ = + ∫ , (2.2) 





y y dα θ ξ δθ ξ ξ′ = − + ⋅ ⋅∫ . 
αt(θ(ξ)) is the linear coefficient of thermal expansion at depth ξ with temperature θ(ξ). The 
echo time shift δτ(y) can then be computed by subtracting Eq. (2.2) from Eq. (2.1): 
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Figure 2.1 Diagram of ultrasound echo time shifts after FUS heating. zone 1 is the temperature 
constant zone from the transducer surface (y = 0) to y0; zone 2 is the heating zone. dξ denotes the 
distance between two scatters, αt the linear coefficient of thermal expansion, δθ the temperature 




















Ultrasound thermometry. Differentiating Eq. (2.3) by the depth variable y, we get the 
time shift gradient ∂(δτ(y))/∂y: 
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, (2.4) 
where the first term in Eq. (2.3) disappears since it is independent of y. For most biological 
materials at a lower temperature range (20 °C – 40 °C), a linear relation between speed of 
sound and temperature can usually be assumed:22,23 














. Although the linear coefficient of thermal expansion αt is itself a 
function of temperature,22 for simplicity we assumed it a constant over the temperature range 
under investigation. Using the fact that ( ) 1yβ δθ⋅   and the assumption of constant αt, 
Eq. (2.4) can be rewritten to  
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Eq. (2.6) is the same as derived by Simon et al.,1 and hence ∂(δτ(y))/∂y is used to estimate the 
temperature changes by 










where k = 1/(αt − β) is material dependent and needs to be pre-calibrated. 
Calibration. To empirically determine k, Eq. (2.7) is integrated from y0 to depth y: 
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where a = c0·k/2 and b = –δτ(y0)·c0·k/2. a and b can be determined by fitting a linear curve to 




dδθ ξ ξ⋅∫  given available ultrasound backscatter data and spatial temperature 
distribution measured with IR thermography. The reason that Eq. (2.7) is not used directly 
for calibration is to prevent large noise and errors when taking the derivative of δτ(y) directly. 
δθ(ξ) measured by IR thermography usually has a smooth distribution which allows the 
integration in Eq. (2.8). 
2.2.2 Phantom fabrication 
The surface of the phantom had to be exposed to air to enable IR imaging, therefore 
to perform ultrasound imaging simultaneously with its probe out of the water (the probe used 
cannot be completely immersed in water), agar-based molds were first fabricated to allow for 
acoustic coupling between the phantom and the probe. The agar-based molds were made with 
1% g/ml agar powder and deionized water. After the molds completely solidified, phantoms 
with desired acoustic and thermal properties were made inside the molds. Two different types 
of phantoms were fabricated: one was a water-based graphite-in-gelatin phantom to mimic 
typical biological tissue, and the other was an oil-based fat-mimicking phantom. These two 
phantoms were chosen due to their differences in speed of sound and thermal expansion as a 
function of temperature. 
Tissue-mimicking phantom. The graphite-in-gelatin phantom24 was constructed using 
0.1 g/ml gelatin powder, 0.07 g/ml graphite powder, 0.0024 g/ml p-toluic acid, and 7% 
2-propanol mixed in deionized water. The mixture was heated slowly on a hot plate with 
magnetic stirrer until the solution was clear. The solution was placed in a vacuum chamber 
for several minutes to remove gas bodies before it was poured into the agar mold. 
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Fat-mimicking phantom. To construct the fat-mimicking phantom,25 a gelatin solution 
and an oil solution were heated separately before mixing them together. The gelatin solution 
consisted of 0.1 g/ml gelatin powder and 1.67% 2-propanol in deionized water, and the oil 
solution consisted of 25% olive oil and 16.67% castor oil (all concentrations were calculated 
based on the final mixture volume). After the gelatin solution became clear, the oil solution 
was slowly mixed into the gelatin solution, during which 1.67% detergent was also added. 
The mixture was stirred thoroughly. Again the mixture was placed in the vacuum chamber 
for several minutes to remove gas bodies before it was poured into the agar mold. 
Emissivity measurement. Emissivity determines the efficiency of a body to radiate 
and absorb energy, and is defined as the ratio of the radiation emitted by the object to the 
radiation emitted by a blackbody at the same temperature.26 It is a dimensionless parameter 
with a value between 0 and 1 with 1 being a perfect blackbody. For accurate conversion from 
IR radiance to temperature, knowledge of the emissivity of the imaged object is required. 
Therefore we first measured the emissivity of the two phantom types using the black tape 
method27 with an IR camera (Silver 5600, FLIR Systems, Boston, MA, USA) perpendicular 
to the phantom surface. The Scotch Super 33+ Vinyl Electrical Tape (3M Company, St. Paul, 
MN) with a known emissivity of 0.95 was used. The importance of accurate measurement of 
emissivity and the ambient temperature to determining object temperature is further 




2.2.3 Ultrasound system, IR imaging, and FUS heating 
The experimental setup (Fig. 2.2A) consisted of the same IR camera used for 
emissivity measurement, an ultrasound imaging system, and a FUS system. The IR camera is 
sensitive to the mid-IR wavelength (3 – 5 μm), with a temperature measurement accuracy of 
± 1 °C and a resolution of 0.01 °C. IR imaging was performed using one integration 
(exposure) times for measurements ranging from 10 °C to 60 °C, and conversion from IR 
radiance to temperature was performed using the manufacturer’s calibration and 
non-uniformity corrections. The ultrasound imaging system (Vevo 770; Visualsonics, 
Toronto, ON, Canada) used had a high-frequency scanhead (RMV 707B, 30 MHz center 
frequency, 12.7 mm focal distance, 2.2 mm depth of focus [−6 dB], 55 μm axial resolution, 
115 μm lateral resolution). The raw radiofrequency (RF) backscattered signals from the RF 
output port of the Vevo system were acquired by a digitizing oscilloscope (54830B, Agilent, 
Santa Clara, CA) at 500 Msample/s. The FUS system consisted of a FUS transducer 
(3.98 MHz center frequency, F = 1, Blatek, Inc., State College, PA), a function generator 
(33220A, Agilent), and a power amplifier (75A250, Amplifier Research, Souderton, PA). 
The FUS transducer was calibrated using a hydrophone (HNR-0500, Onda, Sunnyvale, CA) 
and its −6 dB focal width and focal length were measured as 0.7 mm and 5 mm, respectively.  
Experiments were performed with the FUS transducer submerged in water facing up 
towards the phantom. The top surface of the phantom was above the water level to allow 
temperature measurement with the IR camera positioned above the phantom facing 
downward. The ultrasound imaging probe was placed horizontal and close to the phantom 
surface (Fig. 2.2B) to image the same plane as the IR measurement. To align the IR and 
ultrasound images, a thin metal wire visible under both imaging modalities was bent to 
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90 degrees with one edge inserted into the phantom and the other edge placed on the 
phantom surface. For synchronization, the “line trigger” and “frame trigger” output signals 
from the Vevo system were used to trigger the oscilloscope, FUS system, and IR camera 
through a delay-pulse generator (Model 565, Berkeley Nucleonics Corp., San Rafael, CA).  
The B-mode images consisted of 32 A-lines with a separation of 27.5 μm between 
each pair of A-lines and were acquired at 34.4 Hz frame rate. The FUS exposures (34.4 Hz 
pulse repetition frequency, 51.7 % duty cycle, 0.84 s total duration, focus intensity 
180 – 700 W/cm2) were initiated 12 ms after the B-mode “frame trigger” to interleave with 
the imaging pulses to prevent interference. B-mode images were acquired for 6 frames before, 
30 frames during, and 27 frames after FUS exposures. IR images of the phantom surface 
were acquired continuously for the entire time course at 50 Hz frame rate. 4 sets of 
experiments were performed on the tissue phantom, and 5 were on the fat phantom. All 
experiments were conducted at room temperature (20 °C). 
 
Figure 2.2 (A) Schematic illustration of experimental setup. (B) Photo of the ultrasound (US) probe 
and fat-mimicking phantom embedded in an agar mold. The region of interest is indicated by the red 
box. (C) and (D) show the corresponding ultrasound gray scale (GS) image and IR-measured 














































































2.2.4 Image and data analysis 
All image analysis and computations were performed using MATLAB (R2012a, 
Mathworks, Natick, MA) offline. The time information for both the IR and ultrasound 
images was shifted so that time t = 0 corresponded to the start of FUS exposures. The 
orientation of the x- and y-axis are shown in Fig. 2.2B, with x = 0 corresponding to the center 
A-line of the B-mode image and y = 0 corresponding to the phantom-agar mold interface. We 
applied the 1D model presented in Sec. 2.2.1 to each A-line in the B-mode image, therefore 
in the following equations, the notation of location ‘x’ is only included when 2D spatial 
interpolation or filtering is involved. 
Temperature increase. The temperature increase ΔTIR at location (x, y) at time t was 
calculated from the IR measured temperature TIR by 
 IR IR 0( , , ) ( , , ) ( , , 0)T x y t T x y t T x y t∆ = − ≤ , (2.9) 
where T0(x, y, t ≤ 0) is the baseline temperature averaged from –0.62 s to 0 s before FUS was 
turned on. The cumulative temperature rise up to depth y in Eq. (2.8) was denoted as 
cum[ΔTIR(y)], and computed using  
 ( ) ( ) ( )
0
0




d T y y T yδθ ξ ξ⋅ ≈ ∆ ⋅∆ ∆  ∑∫ , (2.10) 
where ΔyIR is the pixel size on the IR images, and y0 was chosen at a depth with 
ΔTIR(y ≤ y0) = 0.  
To compare with the ultrasound data, ΔTIR(x, y) and cum[ΔTIR(x, y)] at each t was 
linearly interpolated to have the same resolution as the B-mode image (interp2.m function in 
MATLAB). After interpolation, the center peak temperature rise, max[ΔTIR(y)], along each 
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A-line was determined. The spatial location of ‘focus’ (xf, yf) was also determined by 
( ) ( )IR
,
, arg max , , FUS endf f
x y
x y T x y t= ∆ =   . 
Speed of sound. The location of the tip of the reference metal wire yref was first 
determined from the IR image, then the time of arrival of the RF signal from the 












where τ(yref) and τ(y = 0) is the time of arrival of the RF signal from the reference wire and 
the phantom-agar mold interface, respectively. 
Echo time shifts. For each dataset, a reference frame was first computed using the 
mean of the 6 pre-FUS frames. To calculate δτ(y), the A-lines in each B-mode image were 
compared to the corresponding A-lines in the reference frame using the cross-correlation 
function. A tracking window n = 80 points was used (~2.4 λ, where λ is the wavelength of 
the imaging transducer). A fourth-order polynomial was fitted to the 11 points around the 
point with the maximum cross-correlation value, and the location of the final maximal with a 
finer spatial resolution was determined as the displacement. δτ(y) was then calculated by 
dividing the displacement with the sampling rate. Data points with RF signal amplitude 




Thermometry calibration. Eq. (2.8) can now be rewritten as 
cum[ΔTIR(y)] = a·δτ(y) + b. a and b was determined by fitting a linear curve for each A-line 
in each frame. To minimize error from locations with small temperature rise, only the region 
with temperatures greater than 0.2 × max[ΔTIR(y)] was used for the fitting. This region is 
denoted as “focal width” in this chapter. The R-squared value (R2a,b), which is indicative of 
how well the data points fit the line, was recorded so that only cases with a good fit were 
used for statistical analysis.  
Evaluation of temperature estimation. For temperature estimation, a 10th order 
polynomial was fitted to δτ(y) computed using the cross-correlation method. The chosen 
order of polynomial fit was within the range used in Seip et al.’s work (polynomial of order 
between 8 and 14).28 The fitted polynomial was then differentiated along y to obtain the 
gradient of echo time shifts ∂(δτ(y))/∂y. Since all experiments were performed at the same 
room temperature, the speed of sound c0 at the baseline temperature was the same. Therefore, 
the estimated temperature was computed by multiplying ∂(δτ(y))/∂y with a as in Eq. (2.7), 
where a was calibrated using Eq. (2.8). To evaluate the estimation error, leave-one-out cross 
validation (LOOCV) was employed in which each time one set of experiment was used as 
the validation set, and temperature was estimated by using the mean a calculated from the 





2.3.1 Emissivity of phantoms 
The emissivity was measured to be 0.985 ± 0.017 (mean ± standard deviation (S.D.), 
n = 4) for the tissue-mimicking phantom and 0.823 ± 0.031 (n = 4) for the fat-mimicking 
phantom. Therefore for IR imaging in this study, emissivity was set to 0.99 and 0.82 for the 
tissue-mimicking and fat-mimicking phantom, respectively. 
2.3.2 Speed of sound 
Figures 2.2C and 2.2D show an example of the corresponding ultrasound gray scale 
(GS) and IR temperature image. The reference metal pin for image registration is visible on 
both images at depth ~6.3 mm. The baseline speed of sound c0 (at 20.23 ± 0.28 °C) in tissue-
mimicking and fat-mimicking phantom were 1581.3 ± 11.3 m/s (n = 4) and 1444.7 ± 9.7 m/s 
(n = 5), respectively. The mean value was used for subsequent data analysis. 
2.3.3 Thermometry calibration 
Figure 2.3 shows 1D examples of the calibration process using the IR and ultrasound 
data along depth y of the center line (x = 0) at t = 1 s (0.16 s after FUS was turned off) from 
one dataset for each phantom type. cum[ΔTIR(y)] (Figs. 2.3B and 2.3F), which was computed 
using the IR-measured ΔTIR(y) (Figs. 2.3A and 2.3E), is compared against δτ(y) computed 
from the ultrasound RF data (Figs. 2.3C and 2.3F). The region with temperature rise greater 
than 0.2 × max[ΔTIR(y)] is indicated by the grey dashed lines, and the data within the region 
was used to fit for a and b as in Eq. (2.8) (Figs. 2.3D and 2.3H). As cum[ΔTIR(y)] increases 
along y, δτ(y) in the tissue-mimicking phantom becomes more negative (Fig. 2.3C), whereas 
δτ(y) in the fat-mimicking phantom becomes more positive (Fig. 2.3F). We also observed 
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that for a similar cum[ΔTIR], the absolute echo time shifts |δτ| is 2 – 3 times higher in the 
tissue-mimicking phantom than in the fat-mimicking phantom. 
 
Figure 2.3 Examples of the calibration process: (A–D) are data from tissue-mimicking phantom and 
(E–H) from fat-mimicking phantom. (A, E) Temperature rise ΔTIR measured by IR imaging. The 
dashed grey line indicates the region with temperature rise greater than 0.2 × max[ΔTIR]. (B, F) 
Cumulative ΔTIR along depth y, cum[ΔTIR]. (C, G) Ultrasound echo time shifts δτ. (D, H) Linear fit of 
cum[ΔTIR] and δτ. 
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Figure 2.4 shows a 2D spatiotemporal example of the calibration results for the 
tissue-mimicking phantom. During FUS exposures, the size of the heated region grows larger 
and the temperature rise becomes higher, as shown by the spatiotemporal evolution of ΔTIR 
(Fig. 2.4A). The corresponding spatiotemporal evolution of cum[ΔTIR] is shown in Fig. 2.4B. 
For better visualization, Fig. 2.4C shows a normalized echo time shifts δτ′(y) defined as 
 0( ) ( ) ( )y y yδτ δτ δτ′ = − , (2.12) 
where δτ(y0) was computed by averaging δτ(0.5 mm ≤ y ≤ 1 mm). Eq. (2.8) now becomes a 
simple scalar relation: cum[ΔTIR] = a·δτ′(y). Figure 2.4D shows ΔTIR as a function of time at 
the focus (xf, yf), and 0.2 mm and 0.4 mm to the left of the focus (indicated by the white 
crosses in Fig. 2.4A). The corresponding a, and R2a,b calculated for the corresponding A-lines 
containing these three locations are shown in Figs. 2.4E and 2.4F. The calibrated a reaches a 
more stable range of values around −0.60 °C-mm/ns after t = 0.5 s, corresponding to a higher 
R2a,b. An example for the fat-mimicking phantom is also shown in Fig. 2.5. Similarly, the 
calibrated a becomes more stable around 1.52 °C-mm/ns after t = 0.5 s, also corresponding to 
a higher R2a,b. The initial small cum[ΔTIR] at the beginning of FUS exposure induced a small 
δτ, which resulted in a low contrast-to-noise ratio (CNR) that was insufficient for good fitting. 
By considering fitting results with R2a,b ≥ 0.75 from all A-lines in all frames, 
a = −0.59 ± 0.08 (°C-mm/ns) for the tissue-mimicking phantom (n = 4 sets of experiments, 
total of 5186 data points). Using the same criterion, a = 1.49 ± 0.27 (°C-mm/ns) for the fat-
mimicking phantom (n = 5 sets of experiments, total of 5164 data points). Table 2.1 
summarizes the calibrated a for the LOOCV, which was computed by excluding one dataset 





Figure 2.4 Example of calibration for tissue-mimicking phantom: (A) 2D temperature rise ΔTIR 
before, during, and after FUS heating. The time is indicated in white numbers at the bottom of each 
frame in sec. (B) and (C) show the corresponding cum[ΔTIR] and δτ′(y) = δτ(y) − δτ(y0). (D) ΔTIR over 
time at the focus, 0.2 mm and 0.4 mm to the left of focus. The three locations are indicated by the 
white crosses in the first frame in (A). (E) and (F) show the corresponding fitted a and R2a,b along the 
A-lines containing these three locations. 
 
Figure 2.5 Example of calibration for fat-mimicking phantom: (A) 2D temperature rise ΔTIR before, 
during, and after FUS heating. The time is indicated in white numbers at the bottom of each frame in 
sec. (B) and (C) show the corresponding cum[ΔTIR] and δτ′(y) = δτ(y) − δτ(y0). (D) ΔTIR over time at 
the focus, 0.2 mm and 0.4 mm to the left of focus. The three locations are indicated by the white 
crosses in the first frame in (A). (E) and (F) show the corresponding fitted a and R2a,b along the A-
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Table 2.1 Calibration coefficient for ultrasound temperature estimation 
A. Tissue mimicking phantom  B. Fat mimicking phantom 
validate 
set  calibrate set  n points  a (°C-mm/ns)   validate set  calibrate set  n points  a (°C-mm/ns)  
1  2,3,4  3871  -0.6003 ± 0.0825  1 2,3,4,5 4216 1.4812 ± 0.2662 
2  1,3,4  3630  -0.5927 ± 0.0832  2 1,3,4,5 3895 1.5059 ± 0.2775 
3  1,2,4  3832  -0.5902 ± 0.0819  3 1,2,4,5 4415 1.4656 ± 0.2623 
4  1,2,3  4225 -0.5862 ± 0.0710  4 1,2,3,5 4169 1.4832 ± 0.2705 
- - - -  5 1,2,3,4 3961 1.5206 ± 0.2678 
 all  5186  -0.5922 ± 0.0797   all 5164 1.4905 ± 0.2694 
2.3.4 Evaluation of temperature estimation 
Figure 2.6 shows 1D examples of ultrasound temperature estimation for the two 
phantom types at time points during and after FUS exposures. All figures are plotted using 
the center A-line (x = 0) from one dataset. Figs. 2.6A–D show δτ(y) and the 10th order 
polynomial fit. To compare with the polynomial fit, the fitted curve based on known 
temperature distribution measured by IR imaging is also plotted by rearranging Eq. (2.8): 
 IRIR
cum[ ( )]( ) T y by
a
δτ ∆ −= . (2.13) 
Again we see a decrease in δτ(y) with respect to y for the tissue-mimicking phantom and an 
increase for the fat-mimicking phantom. The estimated temperature increase ΔTUS calculated 
from differentiating the polynomial fit along y and multiplying the calibrated a in Table 2.1 
was compared with the measured ΔTIR (Figs. 2.6E–H). A better match between ΔTUS and 
ΔTIR is seen on post-FUS results (Figs. 2.6F and 2.6H) compared to the during FUS results 
(Figs. 2.6E and 2.6G). A larger deviation between δτIR(y) and the polynomial fit is observed 






Figure 2.6 Examples of temperature estimation using echo time shifts with 10th order polynomial 
fitting. (A–D) Echo time shifts δτ determined directly from the ultrasound RF data, the 10th order 
polynomial fit, and the fit δτIR using IR measured temperature. (E–H) Corresponding IR measured 
temperature rise ΔTIR and ultrasound estimated temperature rise ΔTUS. 
 
Figure 2.7 Evaluation of ultrasound temperature estimation: (A–C) one dataset from tissue-
mimicking phantom and (D–F) one dataset from fat-mimicking phantom. (A, D) show the 
spatiotemporal evolution of temperature rise ΔTIR measured by IR imaging. (B, E) The ultrasound 
estimated temperature rise ΔTUS. (C, F) Error = ΔTUS − ΔTIR. The double-sided arrows indicate the 
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Figure 2.7 shows the 2D spatiotemporal ΔTIR and ΔTUS from one dataset for each 
phantom type and the corresponding error: ΔTUS − ΔTIR (Figs. 2.7A–C: tissue-mimicking 
phantom; Figs. 2.7D–F: fat-mimicking phantom). In both phantom types, the error is largest 
during FUS exposure and at the center region of the focal zone (Figs. 2.7C and 2.7F).  To 
evaluate the performance of temperature estimation from all datasets (n = 4 for tissue-
mimicking phantom and n = 5 for fat-mimicking phantom), Fig. 2.8 shows the mean ± S.D. 
error at discrete locations: the focus, 0.25 mm and 0.5 mm away from the focus along the 
same A-line. The ‘+’ and ‘-’ signs in Fig. 2.8 indicate if the locations are towards or away 
from the imaging probe. The range of error in the tissue-mimicking phantom is smaller 
compared to that of fat-mimicking phantom. For both phantom types, the absolute error at the 
focus is the largest and increases during FUS exposures. However, when the FUS is off, the 
error quickly drops to close to zero.  
 
Figure 2.8 Statistical analysis of the ultrasound thermometry error: Mean ± S.D. of error at the focus, 
and ± 0.25 mm, ± 0.5 mm along the same A-line from the focus in (A) tissue-mimicking (n = 4) 
phantom and (B) fat-mimicking (n = 5) phantom. ‘+’: further away from the imaging transducer; ‘−’: 
towards the imaging transducer. 
  
































The main difference between the during FUS and post-FUS temperature distribution 
is the size of the focal width (defined as region with ΔTIR ≥ 0.2 × max[ΔTIR] along each 
A-line.). For example, Fig. 2.9A shows the temperature profiles along the axial depth with 
the same max[ΔTIR] = 5 °C but different focal widths from one tissue-mimicking dataset. 
During FUS exposure, the focal width is smaller compared to that of post-FUS. To further 
investigate the effect of size of focal width on the temperature estimation accuracy, we 
computed the percentage error using  








and combined all A-lines with the same peak temperature at 5 ± 0.5 °C and plot their 
percentage error versus focal width as shown in Fig. 2.9B. A smaller absolute percentage 
error is observed for the post-FUS data with a bigger focal width. 
 
Figure 2.9 Effect of focal width on temperature estimation accuracy: example from one tissue-
mimicking phantom dataset. (A) IR-measured temperature increase ΔTIR along the axial depth for two 
A-lines during and post FUS exposure. The peak temperature is 5 °C for both A-lines. (B) Percentage 
error versus focal width for all A-lines with the same peak temperature = 5 ± 0.5 °C. 
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When combining all A-lines with varying peak temperature and from all n = 4, the relation 
between focal width and error % (Fig. 2.10) still shows that the temperature estimation 
becomes much accurate when the focal width is larger. Similar result is observed for the fat-
mimicking phantom. 
 
Figure 2.10 Percentage error as a function of focal width for the tissue-mimicking phantom. 
2.4 Discussion 
In this study, we investigated the applicability of IR thermography in developing 
ultrasound thermometry where FUS was used as an example thermal heating modality. Echo 
time shifts determined using 1D cross-correlation speckle tracking method were compared 
against the cumulative temperature rise along the same A-line to obtain the material-
dependent coefficient for temperature estimation. The calibrated coefficient was then used 
for ultrasound thermometry through cross-validation, and the ultrasound estimation error was 
computed by comparing against the IR measured temperature. 
  













2.4.1 Calibration of ultrasound thermometry 
All methods for ultrasound thermometry require accurate calibration for the specimen 
being heated.29 For example, in the echo time shifts method used in this study, the knowledge 
of the material dependent k is required. In methods using change of backscattered energy 
(CBE), it is also necessary to know how backscattered energy changes as a function of 
temperature for a specific type of specimen.3 Although calibration done using water-bath 
heating can provide a smaller S.D. and/or error because of the larger heated volume, the time 
required for the water and sample to reach temperature equilibrium is long. In contrast, the 
fast calibration method we proposed using IR thermography only used FUS exposures with 
durations less than 1 s. However, given the small focal zone of the FUS transducer used in 
this study, cum[ΔTIR] = ∑ΔTIR·Δy only resulted in a small δτ, particularly for the fat-
mimicking phantom (Fig. 2.3F: on the order of several ns), which is very susceptive to noise. 
δτ becomes even noisier as depth increases due to the attenuated ultrasound signal strength. 
Therefore for calibration, we have chosen only data points within the center heating zone 
(0.2 × max[ΔTIR]) to minimize errors. This is also demonstrated by the more accurate 
calibration based on IR-measured temperature as the region of temperature rise (‘focal width’) 
increases, especially at time points during the cooling period when FUS is off. To further 
improve accuracy and minimize error, a FUS transducer with a larger focal zone can be used 
to heat up a bigger volume which will result in a larger δτ.  
To integrate ΔTIR along the axial depth, we made an assumption that the speed of 
sound changes linearly as a function of temperature for these two phantom types (Eq. (2.5)). 
Indeed we observed that the calibrated a value was consistent with temperature distributions 
either at a higher ΔTIR (e.g., Figs. 2.5D and 2.5E, t = 1 s) or a lower ΔTIR (t = 1.5 s). 
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Phantoms which can sustain a higher temperature can be used in the future to further expand 
the method to calibrate quadratic relations between speed of sound and temperature rise in a 
wider temperature range. 
The speed of sound and thermal expansion in most soft tissue (water-based) increase 
as temperature increases, whereas in fat (lipid-based) they both decrease as temperature 
increases.22,23 These properties are comparable to the echo time shifts observed in the two 
phantom types used (Figs. 2.3C, 2.3F, 2.4C, 2.5C, 2.6A–D). One of the biggest challenges to 
apply ultrasound thermometry in clinical settings is the uncertainty of the content of the 
imaged tissue, and in-vivo calibration is generally unachievable.  MRI also shares the same 
problem where its unreliable temperature measurement in fat still remains a challenge.30 For 
tissue types that can be classified prior to thermal therapy, a database containing the 
corresponding calibration coefficients for each tissue type can greatly improve the accuracy 
of ultrasound temperature estimation. Using the fast calibration process with IR 
thermography, calibrations can be done on various different tissue types in a fast and 
systematic manner.  
2.4.2 Validation of ultrasound thermometry 
As shown in Fig. 2.9, at the same max[ΔTIR], the temperature estimation has a much 
smaller error when the size of the focal width is wider, which appears after FUS was off. The 
observation is expected as even with known temperature profiles, the calibration fit becomes 
better with a higher R2a,b after FUS was off. The use of a 10th order polynomial to fit δτ and 
then taking the gradient of the polynomial can be considered equivalent to applying a 
narrowband differentiator directly to δτ. In Simon et al.’s work,1 a better spatial resolution of 
temperature estimation from δτ was observed when a broadband differentiator was applied at 
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the trade-off of increased amount of ripples. However, due to the small focal zone and small 
CNR in this work, we did not use broadband differentiators which preserve more noise. As a 
result, the temperature increase was underestimated within the focal zone during FUS 
exposure for both phantoms. To minimize noise and further improve performance, more 
advanced signal processing methods such as those using special filter designs can be 
employed.31 
In previous ultrasound thermometry studies based on echo time shifts, a good 
agreement of temperature estimation and thermocouple measurement (~0.5 °C) was achieved. 
However, in these studies either water-bath experiments with uniform temperature 
distribution were performed or the HIFU transducers and ultrasound imaging probes were 
aligned with the same direction of ultrasound propagation. Therefore the focal width of the 
temperature increase along the imaging axial direction was on the order of several millimeter 
to centimeter scale.1,29,32,33 No study has been able to investigate the limitation on the size of 
focal width for acceptable temperature estimation error due to the lack of spatial temperature 
information. In this study, we were able to investigate a sub-millimeter focal width by 
placing the HIFU transducer and imaging probe in a perpendicular configuration. As shown 
in Fig. 2.6A, when the focal width is small and CNR of δτ is small, a slight difference 
between the slope of the fitted polynomial and that of the fitted δτIR in the focal zone results 
in a big difference in ΔT. Even after applying signal processing methods to minimize noise, 
there will still be a limitation on the size of the heating zone where temperature can be 
precisely estimated using ultrasound imaging. IR thermography has a high spatial resolution 
and can be easily applied to evaluate the performance of ultrasound thermometry as the size 
of heating zone varies. IR images acquired in this study had a pixel size of ~70 μm. In 
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contrast, thermocouples will not be sufficient to provide temperature information with a sub-
millimeter spatial resolution. Our results also suggest that for ultrasound thermometry, the 
axial direction of the imaging plane should be selected to be along the direction which has 
the biggest focal width. 
2.4.3 Temperature measurement errors 
The accuracy of IR thermography in temperature measurement highly depends on the 
accuracy of the emissivity of the specimen, which is used to convert received radiation to 
temperature. The background temperature, which also adds to the total received radiation by 
the IR camera, also needs to be precisely measured to subtract its contribution.34 Table 2.2 
lists examples of the maximum temperature rise converted from the same IR radiation to 
temperature when different emissivity values (mean, mean + S.D., and mean − S.D.) were 
used. The maximum error in IR temperature measurement due to emissivity error is small 
(around ± 0.5°C) in this study. However, when the specimen of interest has a much lower 
emissivity (e.g., < 0.5), care must be taken because temperature conversion from IR radiation 
is more sensitive to emissivity error for low emissivity specimens (see Appendix). 
Table 2.2 Emissivity on IR temperature measurement 
 emissivity max. ΔTIR(°C) 
tissue-
mimicking 
mean−S.D. 0.97 9.15 
mean 0.99 8.95 
mean+S.D. 1.00 8.85 
fat-
mimicking 
mean−S.D. 0.79 8.48 
mean 0.82 8.17 




2.4.4 Limitations and future study 
Although the developed evaluation platform for ultrasound thermometry using IR 
thermography provides high spatial and temporal temperature measurements unavailable 
with other tools and is easy to implement, there are still limitations to this technique. One of 
the main limitation is that the specimen has to have an accessible surface due to the limited 
penetration depth of IR light at thermal sensitive wavelengths. Therefore the technique is not 
applicable for deeply seated tissue parts inside our body. However, it can still be applied 
in-vivo to organs with accessible surface such as the skin. This is more advantageous 
compared to the current water-bath calibration and thermocouple validation methods, which 
are strictly restricted to ex-vivo specimens. 
For future studies, the platform will be applied on real tissue to calibrate tissue 
specific properties and to investigate the threshold of CNR in tissue for accurate temperature 
estimation. We would also like to further investigate the effect of sizes of heating zone, 
which affects the CNR, on the temperature estimation.  
2.5 Conclusions 
The methods described herein suggest that fast calibration and validation of 
algorithms for ultrasound thermometry are possible with the use of IR thermography. 
Accuracy of thermometry calibration can be improved by applying a heat source capable of 
heating up a larger volume. The use of IR thermography also facilitates evaluation of spatial 
resolution of ultrasound thermometry. Although in this study FUS was chosen as the heat 
source and ultrasound processing methods using echo time shifts was used, IR thermography 
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has the potential to be applied to developing ultrasound thermometry for other types of 
thermal therapies and data processing methods. 
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Characterization of lesion formation and bubble activities during high-
intensity focused ultrasound ablation using temperature-derived 
parameters 
In chapter 2 we introduced a new platform to evaluate ultrasound thermometry. 
However, ultrasound thermometry is known to have a limited working temperature range up 
to 50 °C due to the small changes in acoustic properties (e.g., speed of sound) at 
temperatures > 50 °C. Therefore for high-intensity focused ultrasound (HIFU) ablation 
monitoring, an alternative imaging method is needed. It is also critical to establish a better 
understanding of the temperature distribution during HIFU heating as well as the temperature 
characteristics relevant to HIFU events such as tissue coagulation and bubble activities. 
Therefore in this chapter, we developed a system using infrared (IR) thermography and 
bright-field imaging to measure tissue surface temperature during the course of HIFU 
application and to correlate HIFU events with several temperature-derived parameters. The 
threshold for tissue thermal damage based on temperature time history was also 
experimentally determined for porcine cardiac tissue. Although IR thermography is limited to 
monitoring HIFU ablation when the focus is placed near an accessible tissue surface, the 
identified relations between temperature changes and HIFU events are applicable in general. 
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The work in this chapter has been published in Infrared Physics & Technology 60, 
108-117 (2013) entitled “Characterization of lesion formation and bubble activities during 
high-intensity focused ultrasound ablation using temperature-derived parameters”.  
3.1 Introduction 
During HIFU heating, the tissue temperature evolves as a function of time and spatial 
location as described by the bioheat equation1-3 
 m ex
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, (3.1) 
where T is the temperature (oC), t is the time (s), κ is the thermal diffusivity (m2/s), and τ is 
the perfusion time constant (s). Qm is the metabolic heat generation (oC/s) and Qex is the 
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where αab and αatten are the absorption and attenuation coefficient (neper/MHz-cm), f is the 
ultrasound frequency (MHz), cυ is the volume specific heat (J/cm3∙K), and I0 is the ultrasound 
free-field intensity (W/cm2). The ultrasound intensity at a given spatial location is its free-
field intensity attenuated by the exponential term where the effect of attenuation is integrated 
along the beam propagating path. 
Temperature monitoring during HIFU ablation is important because tissue necrosis or 
lesion formation depends on the thermal dose4-6 which is determined by the cumulative effect 
of heat deposited in the tissue. Given the threshold of tissue damage as evaluated by the 
critical cumulative equivalent minutes at 43 °C (CEM43) for a specific tissue type, the 
evolution of lesion extent can be predicted.7,8 Typically, a critical CEM43 of 240 min has been 
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used extensively to predict tissue coagulation in kidney, liver, and muscle,9,10 although it 
actually varies across species as well as tissue types.11 The true threshold is often difficult to 
obtain due to the difficulty in determining the temporal temperature profile during lesion 
formation. Also, prediction errors may arise when the value used was obtained from 
experiments with a much different temperature range or heating mechanism (e.g., heating 
rate, intensity).12  
During HIFU application, lesion formation results in changes of the thermal, 
mechanical, and acoustic properties of the tissue. These changes, along with other events 
induced by HIFU heating, can alter the course of temperature evolution. In particular, 
degassing, boiling, vaporization, and cavitation in tissue13,14 often occur due to excessive 
heating, rapid temperature increase, and high level of acoustic pressures. In some cases, the 
combined effect of high acoustic pressure and rapid heating may generate unwanted 
macroscopic cavities or tissue fragmentation. These events, which result in destruction of 
local tissue integrity and changes of material properties, not only cause inefficient ablation of 
distal tissue segments15 and altered lesion location, shape, and size from the original 
treatment plan, but also render the prediction of tissue status from temperature measurement 
difficult. 
Given the above concerns, it is therefore necessary to provide a system to measure the 
spatiotemporal temperature distribution during HIFU application and determine temperature 
characteristics relevant to HIFU events such as tissue coagulation and bubble activities. It is 
also important to build a system capable of measuring the critical CEM43 for any tissue type 
of interest.  
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As demonstrated in Chapter 2, IR thermography has its advantage in easy 
implementation and capability of non-contact, real-time monitoring of surface temperature 
with high temporal and spatial resolution. Laparoscopic IR systems have also been developed 
and used in assessing tissue necrosis during radiofrequency ablation16 and tested on porcine 
models to provide additional anatomic and physical details from the differences in 
temperature between adjacent structures and organs.17,18 However, IR thermography has only 
been used in a few HIFU-related studies, in which the two dimensional (2D) spatiotemporal 
IR images of temperature were not fully exploited. 
Therefore in this chapter, we employed IR thermal imaging with synchronized bright-
field imaging to measure temperature during HIFU exposures and determined useful 
temperature-derived markers indicative of HIFU events. Experiments were conducted using 
ex-vivo cardiac tissue, for the purpose of ultimately improving HIFU ablation of cardiac 
arrhythmia.19,20 We used IR imaging to measure tissue surface temperature during HIFU 
ablation. We first conducted experiments with the HIFU focus placed close to and slightly 
below the tissue surface where lesion formation and other events can be observed on the 
surface. In this way, changes in temperature-derived parameters related to lesion formation, 
overheating and bubble formation during HIFU application could be identified to permit 
corroboration of tissue changes with temperature measurements by IR imaging. This 
registered observation also allows computation of the thermal dose and determination of the 
critical CEM43 for myocardium tissue. We then extended our experimental studies to 
subsurface HIFU ablation to identify the characteristic temperature behaviors in this context. 
Finally, we investigated the potential of using lower intensity, non-ablative focused 
ultrasound (FUS) exposures in conjunction with IR imaging to detect the presence of lesion.  
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3.2 Materials and methods 
3.2.1 Tissue specimens and emissivity measurement 
Ex-vivo porcine myocardium tissue specimens obtained from a local abattoir were 
used in this study. We used the same IR camera (Silver 5600, FLIR Systems, Boston, MA, 
USA) described in Sec. 2.2.2. To measure the emissivity ε for myocardium, a flat surface of 
the tissue specimen was imaged with the IR camera perpendicular to the surface. Emissivity 
was measured using the black tape method21 where the Scotch Super 33+ Vinyl Electrical 
Tape (3M Company, St. Paul, MN, USA) with a known emissivity of 0.95 was used. The 
emissivity of coagulated myocardium was also measured after coagulation in a microwave 
oven, where different levels of dehydration were generated by applying various durations of 
microwave exposure. 
3.2.2 Experimental setup and IR imaging 
The schematic of the IR-HIFU system is shown in Fig. 3.1. IR imaging was 
performed using two integration (exposure) times for measurements ranging from 15 °C to 
120 °C, and conversion from IR radiance to temperature was performed using the 
manufacturer’s calibration and non-uniformity corrections.  
To generate HIFU exposures with adjustable amplitude and duration, the HIFU 
system used two function generators (33220A, Agilent, Santa Clara, CA, USA), a power 
amplifier (325LA, ENI, Rochester, NY, USA), and a focused transducer (3.98 MHz center 
frequency, F = 1, Blatek, Inc., State College, PA, USA). The HIFU transducer was calibrated 
using a hydrophone (HNR-0500, Onda, Sunnyvale, CA, USA) and its − 6 dB focal width and 
focal length were measured as 0.9 mm and 4.6 mm, respectively. Experiments were 
performed with the transducer submerged in water facing up towards a tissue specimen with 
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its top surface above the water level to allow IR temperature measurements at a 50 Hz frame 
rate. (The tissue needed to be submerged on the underside to allow HIFU propagation in the 
specimen.) A plastic holder with an acoustically transparent bottom (Tegaderm, 3M, St. Paul, 
MN, USA) was used to hold the specimen and to prevent water from permeating into the 
tissue during HIFU exposures. 
The IR camera was positioned perpendicular to the tissue surface, while an angled 
video camera at 24 Hz frame rate (D5000, Nikon, Melville, NY, USA) was used for bright-
field imaging to monitor the tissue surface and identify lesion, cavity formation, and water 
extraction or tissue dehydration due to HIFU application. An indented ruler visible in both 
bright-field and IR images was placed on the edges of the tissue specimen for alignment. 
HIFU exposures and IR imaging acquisition were synchronized by a data acquisition system 
(OMB-DAQ-3000, Omega Engineering, Stamford, CT, USA). Bright-field imaging was 
synchronized by capturing a green LED light signal which turned on when IR imaging 
started. All image analysis and computations were performed using MATLAB (R2010a, 
Mathworks, Natick, MA, USA) offline. 
 
Figure 3.1 Schematic diagram of the experimental setup for IR thermography with HIFU heating. 
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3.2.3 HIFU ablation  
Ablation was conducted using continuous wave HIFU exposures (1060 and 
1500 W/cm2 focal intensity) with various exposure durations. To only induce temperature 
increase within the tissue without generating tissue coagulation as a control, non-ablative 
(125 and 283 W/cm2) continuous wave HIFU exposures were used. The HIFU parameters 
were chosen based on previous experiments to ensure the desired outcome (i.e., with or 
without generating lesion). IR imaging and bright-field imaging were performed before, 
during, and after HIFU application. Gross images of the tissue cross-section were taken after 
HIFU application and outcomes were classified into three categories: (1) non-ablative: no 
lesion was formed, (2) normal lesion: lesion formed without signs of cavitation or excessive 
heating, and (3) overheated lesion: lesion with cavity and/or discoloration within the lesion 
core that may be associated with changes beyond coagulation, such as dehydration and/or 
charring/carbonization. Only cases which could be clearly classified were included in this 
study. 
3.2.4 Bright-field imaging 
To determine the evolution of the lesion on the tissue surface, bright-field images 
were analyzed by first converting the true color RGB images into grayscale images using the 
rgb2gray.m function in MATLAB. After image conversion, a converted pre-HIFU reference 
frame was subtracted from all frames in the video sequence to generate “processed bright-




To ensure that tissue discoloration is an indication of coagulation, in our preliminary 
experiments, we stained tissue specimens with HIFU lesions using Masson’s Trichrome and 
the lesion boundaries matched well between the bright-field image and histology (Fig. 3.2). 
However, histology stain was not used in this study to correlate with temperature-derived 
parameters due to its limitation to post-treatment assessment and distortion of tissue 
geometry during sectioning. 
 
Figure 3.2 (A) Gross image and (B) corresponding histology with Masson’s trichrome stain on 
porcine cardiac tissue with two regions of HIFU-induced thermal lesions. 
3.2.5 Time derivatives of temperature change 
To characterize lesion and bubble formation, the first and second order time 
derivatives of temperature were calculated from the experimental data using  
 ( ) ( , , ) ( , , ), ,
2
T T x y t t T x y t tx y t
t t




 ( ) ( ) ( )
2
2 , , , , , , 2
T T Tx y t x y t t x y t t t
t tt
∂ ∂ ∂ ≈ + ∆ − −∆ ∆ ∂ ∂∂  
, (3.4) 
where Δt is the duration between IR frames. A second order low-pass Butterworth filter with 
−3dB cutoff frequency of 2.5 Hz was applied to the temporal temperature data prior to taking 
the first derivative, and another one with −3dB cutoff frequency of 5 Hz was applied to the 
5 mm5 mmA                                                        B  
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first time derivative before taking the second time derivative. Because the initial rate of 
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was also computed to better allow for comparison between different exposure intensities and 
different spatial locations. Its corresponding normalized second derivative was computed 
from Eq. (3.5) by 
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3.2.6 Thermal damage 









= ∆∑ , (3.7) 
where T  is the average temperature during time ∆t, tf is the final time, R = 0.25 below 43 °C, 
and R = 0.5 above 43 °C. To determine the critical CEM43 for myocardium, one sequence of 
IR images and bright-field images where lesion formation was observed at the surface during 
HIFU ablation (1060 W/cm2, 10 s, focused at 3 mm beneath surface) was analyzed. For the 
purposes of computing CEM43, the lesion must be formed only by thermal effects. As such, 
experimental data were selected to have no observable generation of bubbles or cavities on 




The processed bright-field images were first resized to have the same resolution as 
the IR images using bicubic interpolation (imresize.m function in MATLAB). Then the 
lesion boundaries were manually segmented on the processed bright-field images based on 
the gray-scale intensities at five different time points (t = 6, 7, 8, 9, 10 s) when the surface 
lesion grew large enough to have distinguishable lesion boundaries. The true lesion binary 
masks were formed with the areas inside the boundaries identified as lesions and outside as 
non-lesions. The CEM43 images at the corresponding time frames were computed using 
Eq. (3.7).  
3.2.7 Receiver-operating characteristic (ROC) curves 
To determine the thresholds for lesion and bubble formation based on the data 
derived from the temperature measurements (e.g., θ ) and the critical CEM43 for lesion 
formation, classifications based on ROC curves23 were used.  
For any given CEM43 image, a time threshold τ can be applied to classify each pixel 
as lesion (CEM43 > τ) or non-lesion (CEM43 < τ) and thereby form a “predicted lesion” binary 
matrix at each τ. By comparing the “predicted lesion” binary matrix with the “true lesion” 
binary mask from the processed bright-field images, the number of pixels that were true 
positive (TP), false positive (FP), true negative (TN), and false negative (FN) were calculated 
at each τ. (A pixel was considered to be TP if it was predicted to be lesion and actually was 
lesion, FP if it was predicted to be lesion but was not lesion, TN if it was predicted not to be 
lesion and was not lesion, and FN if it was predicted not to be lesion and was lesion.) An 
overall empirical ROC curve can be drawn by plotting the true positive fraction 
(TPF = TPtotal / Ptotal) versus the false positive fraction (FPF = FPtotal / Ntotal) where the 
58 
 
number of pixels were summed from the five frames, i.e., 
5
1=
=∑total iiTP TP . The area under 
curve (AUC) was computed to evaluate the performance of the classifier τ. The accuracy at 
each threshold is calculated as (TPtotal + TNtotal) / (Ptotal + Ntotal), and the critical CEM43 was 
determined by finding the τ value which resulted in the maximum accuracy. The thresholds 
for lesion and bubble formation based on the data derived from temperature measurements 
were determined following a similar procedure. Due to the imbalanced number of datasets 
for ablative and non-ablative experiments, the non-ablative datasets were over-sampled using 
the synthetic minority over-sampling technique (SMOTE24) prior to performing ROC 
analysis in the determination of the lesion formation threshold. 
3.2.8 Thermal probing: non-ablative FUS heating on HIFU lesions 
To investigate the spatiotemporal temperature distribution affected by the presence of 
HIFU lesions, in addition to the experiments where surface temperature was measured during 
the HIFU ablation, two sets of experiments were performed with FUS exposures applied on 
tissues with pre-generated subsurface HIFU lesions (ex-vivo porcine myocardium 
Specimen 1 and 2). We refer the process of applying the lower intensity, non-ablative FUS 
exposures to characterize tissue properties as “thermal probing”. In these experiments, FUS 
exposures (125 W/cm2, 100% DC, 5 s) were applied with the focus placed at 3 mm beneath 
the tissue surface to induce temperature increase without generating tissue changes. FUS 
probing exposure was applied before any lesion generation in the tissue as a control. Multiple 
ablative FUS exposures (1500 W/cm2) were applied to generate lesion in the subsurface 
volume in each tissue specimen, with the lesion in Specimen 2 purposely generated to be 
larger than the lesion in Specimen 1. Post-lesion thermal probing exposure with the same 
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intensity and duration as the control was then applied to induce temperature increase without 
generating additional tissue coagulation. IR images before and after lesion formation were 
compared using the temperature rise, computed using ∆T (x, y, t) = T (x, y, t) – Ť (x, y, t < 0), 
where T (x, y, t) is the measured surface temperature at a given spatial location (x, y) at time t 
and Ť (x, y, t < 0) is the temporal average temperature from 0 to 2 seconds prior to FUS 
application. The pre-lesion temperature rise images were subtracted from the post-lesion 
images in order to detect the changes in tissue properties to reveal the presence of HIFU 
lesion. 
3.3 Results and discussion 
3.3.1 Emissivity of porcine myocardium tissue 
The emissivity of porcine myocardium tissue specimens used in our study was measured 
to be 0.857 ± 0.006 (n = 3), in agreement with the reported epicardium emissivity 
(0.84 − 0.89) measured using a monochromator.25 The emissivity of microwaved 
myocardium was measured to be 0.82 – 0.84, with the lower value corresponding to the more 
dehydrated specimens. These results are consistent with a previous study where dehydration 
in skin leads to decreased emissivity.26 In this study, emissivity was set to 0.86 for IR 




3.3.2 Characteristic features of spatiotemporal evolution of temperature during HIFU 
ablation  
In these experiments (total n = 28), the HIFU focus was placed slightly below the 
tissue surface (0 – 3 mm) such that lesions induced by HIFU readily extended to the surface 
and were observable by bright-field imaging. Figure 3.3 shows a typical example of 
synchronized IR images (Fig. 3.3A) and bright-field images (Fig. 3.3B) of the tissue surface 
during an ablative HIFU exposure (1060 W/cm2, 20 s). Temperatures as a function of time at 
different locations are shown in Fig. 3.3C. 
 
Figure 3.3 IR measurement of temperature with ablative HIFU exposure (1060 W/cm
2
, 20 s) with 
focus placed at the surface. (A) IR images showing the surface temperature T (°C). The spatial peak 
temperature (cyan cross) is indicated in the images after t = 6 s, deviating from the original center 
focus (white cross). (B) Bright-field images of the tissue surface showing lesion and cavity formation. 
The bright stripe on the left of each image is due to the presence of some water. (C) Time evolution of 





Several characteristics were identified in the spatiotemporal evolution of the surface 
temperature during HIFU ablation. First, at and near the HIFU focal location, the 
temperatures increased rapidly initially (< 0.5 s after HIFU application at t = 0 s), while the 
rate of temperature increase (slope or ∂T/∂t) quickly dropped from the maximum value, as 
expected from prediction of linear bioheat equation with a constant heat source. However, at 
about t = 0.8 − 1 s, the temperature slope increased again, indicating faster rise of 
temperature. This sudden enhanced increase of temperature corresponded to lesion formation 
as identified by the bright-field images (Fig. 3.3B). Second, as heating continued, a small 
cavity formed near the focus (t = 3 s) and the temperature (Fig. 3.3C) correspondingly 
showed irregular variations. Third, a small pocket of water came out of the tissue and 
accumulated near the lesion/cavity area (t = 6 s), accompanied by a flattening of the 
temperature profile, deviating from the expected increase of temperature predicted by the 
bioheat equation.1-3 The temperature stayed almost constant near 100 °C until the end of the 
HIFU (t = 20 s), after which the temperature decreased. Temperatures at locations farther 
away from the focus without lesion formation increased during HIFU exposure and 
decreased smoothly after HIFU exposure as expected. 
Temperature changes during HIFU lesion formation. Correlation of lesion formation 
with the sudden increase in ∂T/∂t shown in Fig. 3.3 is further illustrated by a closer 
examination of the temperature change in the first 2.4 s (Figs. 3.4A – C and 3.5A – C). In 
particular, the time point of the reversal of T t∂ ∂  (Fig. 3.5B, solid arrow) can be easily 
identified by the zero-crossing of ∂2T/∂t2 (Fig. 3.5C, solid arrow). In contrast, in a tissue 
exposed to HIFU intensity of 283 W/cm2 (5 s duration) without lesion generation 
(Figs. 3.4D, 3.4E, 3.5D – F), ∂T/∂t continued to decrease from its initial maximum in the 
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course of temperature evolution (Fig. 3.5E) without zero-crossing (Fig. 3.5F). The zero-
crossing of ∂2T/∂t2 was observed to correspond to surface lesion formation in most 
experiments. To compare between exposures of different intensities (in different experiments 
and at different spatial locations) based on these observations, we developed a criterion for 
lesion identification from the maximum value of the normalized second time derivative 
 *max max ( , , ) over <  endx y t t t tθ θ = <    (3.8) 
where t* is the time of minimum θ  (e.g., as indicated by the dotted arrows in Figs. 3.5C and 
3.5F) at the start of HIFU exposure (0 − 1 s) at each (x, y) location within 0.3 mm (smaller 
than half the focal width) from the HIFU focus, and tend is the end time of HIFU exposure. To 
avoid errors from noise when taking derivatives from small temperature changes, only θ  
with ∂T/∂t > 2 °C/s were considered. Figure 3.6 shows the histogram of maxθ for all ablative 
(including HIFU outcomes of normal and overheated lesions, n = 22, 549 locations, where 
each location is represented by one pixel in the IR images) and non-ablative (n = 6, 222 
locations) experiments. This classifier was determined to have an ROC AUC of 0.999 and 
with a threshold of maxθ = 0.05 s
−1 providing 99.1 % accuracy for lesion identification. The 
threshold is close to zero as expected, corresponding to an occurrence of zero-crossing when 








Figure 3.4 (A – C) Ablative HIFU exposure with focus placed at the surface: Zoomed-in images of 
the first 2.4 s in Fig. 3.3 showing (A) IR images of the surface temperature T (°C), (B) images of the 
rate of temperature change ∂T/∂t (°C/s), and (C) processed bright-field images of the tissue surface 
showing lesion formation. The red line indicates the lesion boundary. (D – E) Non-ablative HIFU 
exposure with focus placed at the surface: The first 2.4 s during a non-ablative HIFU exposure 
(283 W/cm
2




Figure 3.5 Time evolution of temperature T (°C), the rate of temperature change ∂T/∂t (°C/s), and the 
second derivative of temperature change ∂2T/∂t2 (°C/s2) corresponding to Fig. 3.4. The points at the 
focus and 0.25 mm and 0.5 mm to the right of the focus are shown (indicated on the first IR image in 
Figs. 3.4A and 3.4D. (A – C) Ablative HIFU exposure: Extra heating is indicated by the solid cyan 
arrows at 0.8 − 1 s when lesion starts to form. (D – F) Non-ablative HIFU exposure: ∂T/∂t continues 
to decrease without any reversal. The dotted purple arrows indicate the time point when ∂2T/∂t2 
reaches its minimum value. 
 
 
Figure 3.6 Determination of the criterion for surface lesion formation: Histogram of the maximum 
normalized second derivative of temperature change maxθ for non-ablative and ablative HIFU 
ablations. The dashed line indicates a threshold of maxθ = 0.05 s
−1 which provided the highest 




The increase in ∂T/∂t, or the zero-crossing of maxθ , can be explained by the increase 
in acoustic attenuation coefficient in the coagulated tissue compared to normal tissue,27,28 
resulting in enhanced absorption of ultrasound energy and HIFU heating. The faster rate of 
temperature increase will be even more significant if the temperature was corrected to 
account for the changes in emissivity due to lesion formation (see Sec. 3.3.1). This increase 
in heating rate has been observed in previous studies using thermocouples.29 As the 
attenuation and absorption are affected by temperature and thermal dose CEM43,30 the 
increase in the heating rate is most significant when a high thermal dose is deposited in a 
short period of time. 
Overheating: cavity formation and water extraction. During HIFU exposures 
(intensity > 1000 W/cm2), small cavities often appeared after lesion formation, as shown by 
the bright-field images (e.g., Fig. 3.3B, t = 3 s). As a result, the temperature near the focus 
became unsteady (Fig. 3.3C, t > 3 s), due to the loss of tissue integrity. Eventually, the spatial 
temperature distribution around the lesion became irregular and asymmetric (Fig. 3.3A, 
t > 6 s), accompanied by the appearance of water near the lesion/cavity area which seemed to 
be released/extracted from tissue bulk itself (the tissue specimen was water-sealed from 
below). 
Cavity formation can be attributed to thermally-mediated gas pockets and cavitation 
associated with high acoustic pressures. In most cases with apparent cavity formation, an 
asymmetric temperature distribution was observed. To describe the asymmetric temperature 
distribution, we denoted the displacement of the spatial location of the peak temperature (e.g., 
Fig. 3.3A, cyan cross) from the initial center (e.g., Fig. 3.3A, white cross) at time t as d(t). 
Figure 3.7 shows a box plot of the maximum displacement dmax during the entire time course 
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of the HIFU exposure, where dmax = max[d(t)] over t = 0 < t < tend. Using the unequal 
variance t-test (Behrens-Fisher problem), dmax for ablative HIFU exposures with overheating 
and/or cavity formation (mean ± S.D. = 0.315 ± 0.113 mm, n = 15) was significantly 
different from cases of non-ablative (0.075 ± 0.039 mm, n = 6, p < 0.001) and normal 
ablative HIFU exposures (without overheating) (0.143 ± 0.130 mm, n = 7, p = 0.01). No 
significant difference existed between the cases of non-ablative and normal ablative HIFU 
exposures (p = 0.22). The threshold to distinguish between overheated and normal lesions is 
0.16 mm providing 90.9 % accuracy with an ROC AUC of 0.86. Therefore dmax can be used 
to identify excessive heating during HIFU applications. 
 
Figure 3.7 Determination of criterion for overheated surface lesions: Maximum displacement of 
spatial peak temperature location dmax from surface HIFU ablation experiments for non-ablative, 
normal lesion, and overheated lesion cases. The level of statistical significance compared with the 
overheated lesion cases is represented by triple asterisk (***) if p < 0.001and single asterisk (*) if p 
< 0.05. A threshold of 0.16 mm provides the highest accuracy to differentiate between normal and 




 Thermal damage threshold. The lesion regions, determined from the bright-field 
images, were used to find the thermal damage threshold for the myocardium tissue specimens. 
The true lesion boundary was determined manually on each of the processed bright-field 
image, as shown by the example in Fig. 3.8A (t = 9 s in the HIFU experiment: 1060 W/cm2, 
10 s, focused at 3 mm beneath surface). The corresponding CEM43 image (Fig. 3.8B) was 
thresholded by a set of times τ ranging from 0 to 5 × 103 min. The overall ROC curve 
(Fig. 3.8C) was calculated from the average of TP, TN, FP, and FN from the five frames 
(t = 6, 7, 8, 9, 10 s, each with a different lesion size), and the AUC was 0.99. From the 
overall accuracy curve (Fig. 3.8D), the optimal critical CEM43 for lesion formation is 170 
min. The predicted lesion boundary using CEM43 = 170 min is indicated on the processed 
bright-field image and the CEM43 image (Figs. 3.8A and 3.8B), within the normal range of 
soft tissues (40‒240 min11). 
 
Figure 3.8 Determination of the critical CEM43: (A) Processed bright-field image (t = 9 s) with lesion 
at the center, mapped with true lesion boundary (red) and the predicted lesion boundary using critical 
CEM43 = 170 min (blue). (B) Corresponding parametric image of CEM43 on a logarithmic scale. (C) 
Overall empirical receiver-operating characteristic (ROC) curve with area under the curve (AUC) = 
0.99. (D) Overall accuracy as a function of threshold τ. The maximum accuracy occurs at 170 min. 
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 The critical CEM43 for cardiac tissue has been estimated to be 128 min5 but has not 
been experimentally determined. In this study, by deliberately forming the lesion on the 
tissue surface and evaluating the spatiotemporal temperature increase with confirmed lesion 
formation, the threshold of tissue coagulation was readily determined experimentally. 
Although ex-vivo samples lack perfusion and tissue viability which could affect how the 
thermal damage can be assessed,11 the use of IR imaging to determine the thermal damage 
threshold can be easily carried out in both ex-vivo and in-vivo studies on various different 
tissue types and specimens. 
3.3.3 Spatiotemporal temperature changes for subsurface HIFU ablation 
In these experiments (total n = 39), the focus of the HIFU transducer was placed 3 –
 8 mm beneath the tissue surface. The spatiotemporal temperature measured on the surface 
was correlated with HIFU events occurring at the subsurface volume based on characteristics 
observed from the experiments with lesion formation on the surface (Sec. 3.3.2). 
Temperature changes during HIFU lesion formation. Figure 3.9 shows an example of 
the IR images (Fig. 3.9A), ∂T/∂t images (Fig. 3.9B), and the corresponding bright-field 
images of the surface (Fig. 3.9C) from an ablation experiment (1060 W/cm2, 10 s) with the 
focus placed at 3 mm beneath the surface. As in the case of surface ablation, the temperature 
at the surface above the HIFU focus increased rapidly after the start of HIFU application. The 
value of ∂T/∂t was the highest at the start of the HIFU exposure and then decreased. A 
reversal of ∂T/∂t which corresponded to the zero-crossing of ∂2T/∂t2 occurred at 2 s 
(Figs. 3.9B and 3.9E, Marker [1]), suggesting subsurface lesion formation based on the 
similar characteristics as those of surface lesion formation (e.g., Figs. 3.4B and 3.5B, starting 
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t = 1 s) despite no visible surface lesion and CEM43 of 0.42 min at the center point (Fig. 3.9F, 
Marker [1]). ∂T/∂t continued to increase after 2 s, and lesion appeared on the surface at 3.5 to 
4 s (Fig. 3.9C), when the CEM43 was from 111 to 802 min. The CEM43 reached 170 min at 
3.62 s (Fig. 3.9F, Marker [2]). The gross image of the lesion cross-section is shown in 
Fig. 3.9G. 
 
Figure 3.9 Ablative HIFU exposures (1060 W/cm
2
, 10 s duration) with the focus placed at 3 mm 
beneath the surface. (A) IR images showing the surface temperature T (°C). (B) Images of the rate of 
temperature change ∂T/∂t (°C/s). (C) Bright-field images of the tissue surface showing lesion 
formation. (D) Time evolution of T at the center and 0.25 mm and 0.5 mm below the center (indicated 
on the first IR image in (A)). (E) Corresponding time evolution of ∂T/∂t: [1] ∂T/∂t starts to increase at 
2 s, suggesting lesion formation in subsurface; [2] The CEM43 reaches 170 min at 3.62 s, predicting 
lesion formation at the surface between 3.5 and 4 s (see frame with arrow in (C)). The upper-right box 
shows the time evolution of ∂2T/∂t2 (°C/s2) at the center. The first zero-crossing occurred at 2 s. (F) 
Corresponding time evolution of CEM43: [1] 0.42 min at 2 s; [2] 170 min at 3.62 s. (G) Gross image 
of the lesion cross-section. Axial is the direction which ultrasound beams propagated, from the 
bottom surface of the tissue to the top surface. 
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Using the criterion developed for lesion identification defined in Eq. (3.8), we 
classified the sets of experiments with a subsurface HIFU ablation based on the surface 
temperature measurements. We only considered θ  with ∂T/∂t > 0.5°C/s, which is a lower 
criterion compared to surface ablations (Sec. 3.3.2) due to the smaller temperature rise. Two 
sets of experiments were excluded due to skipped IR images, resulting in varying time 
intervals ∆t which prohibited comparable time derivatives of temperature. Figure 3.10 shows 
the histogram of maxθ for all ablative (including HIFU outcomes of normal and overheated 
lesions, n = 30, 2102 locations) and non-ablative (n = 7, 363 locations) experiments. This 
classifier was determined to have an ROC AUC of 0.80 and with a threshold of maxθ = 0.03 
s−1 providing 84.1 % accuracy for lesion identification. When the lesion is at a larger depth, 
its effect on the surface temperature is reduced due to the longer distance for heat conduction 
to reach the surface. This also explains the smaller AUC compared to the classification with a 
surface HIFU focus (0.999, see Sec. 3.3.2). 
 
Figure 3.10 Determination of criterion for subsurface lesion formation: Histogram of the maximum 
normalized second derivative of temperature change maxθ for non-ablative and ablative HIFU 
ablations. The dashed line indicates a threshold of maxθ = 0.03 s
−1 which provided the highest 




Overheating: cavity formation and tissue dehydration. We examined whether similar 
characteristics of temperature irregularities, stagnation, and asymmetric distribution observed 
with the occurrence of cavity formation and tissue dehydration (or water extraction from 
tissue) in the cases of surface ablation (Sec. 3.3.2) can be regarded as indications of excessive 
heating in subsurface HIFU ablation.  
Figure 3.11 shows a comparison of three temperature profiles from experiments 
where HIFU exposures (1500 W/cm2) with durations of 5, 10, and 15 s were applied with the 
focus placed at 5 mm beneath the tissue surface. The temperature images (Fig. 3.11A) and 
time profiles (Figs. 3.11D and 3.11E, red line) for the shorter exposure ablation were smooth 
with no abrupt increase in ∂T/∂t. (The effect of lesion formation on the surface temperature 
was reduced in these cases due to the longer distance for heat to conduct to the surface.) The 
gross image of the corresponding tissue section (Fig. 3.11F) shows a small lesion with no 
sign of cavity formation.  
With longer exposure times (10 and 15 s) (Figs. 3.11B and 3.11C), the temperature 
profiles (Fig. 3.11D, green and blue lines, respectively) showed the temperature reaching a 
plateau with a slight drop around 8 s while the HIFU exposure was still on. Afterwards, 
asymmetry in the spatial distribution of the temperature was observed, with the location of 
the peak temperature shifted away from its original central location with time. This is similar 
to the cases with surface ablation where cavity formation and tissue dehydration/water 
extraction were observed. Although no direct correlation of subsurface HIFU events with the 
temperature evolution was obtained, lesions observed in the gross images (Fig. 3.11F) 
exhibited discoloration in the lesion core which is often associated with overheating. The 
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Figure 3.11 Three sets of IR images of temperature T (°C) during ablative HIFU exposures 
(1500 W/cm
2
) with the focus placed at 5 mm beneath the surface. Duration of HIFU exposures is (A) 
5 s, (B) 10 s, and (C) 15 s. The spatial peak temperature (cyan cross) and the original center focus 
(white cross) are indicated in (B) and (C). (D) Time evolution of the temperature change 
ΔT(t) = T(t)−T(t = 0) and (E) the rate of temperature change ∂T/∂t (°C/s) at the center of the 
temperature distribution. (F) Gross images of the lesion cross-sections. The white contours indicate 
manually-drawn lesion boundaries, and the red arrows indicate regions with discoloration, suggesting 
overheating. Axial is the direction which ultrasound beams propagated, from the bottom surface of 





Figure 3.12 shows a box plot of dmax from surface temperature measurements in 
subsurface HIFU experiments. Using the unequal variance t-test, dmax for ablative HIFU 
exposures with overheating (0.842 ± 0.631 mm, n = 15) was significantly different from the 
non-ablative (0.206 ± 0.081 mm, n = 8, p < 0.01) and ablative HIFU exposures without 
overheating (0.204 ± 0.058 mm, n = 16, p < 0.01) cases. No significant difference occurred 
between the non-ablative and ablative HIFU exposures without overheating cases (p = 0.96). 
The threshold to distinguish between overheated and normal lesions is 0.29 mm providing 
93.5 % accuracy with an ROC AUC of 0.99. dmax of the overheated lesions is larger in these 
experiments compared to the surface HIFU experiments (0.315 ± 0.113 mm, see Fig. 3.7), 
probably because the ultrasound propagation was blocked and/or disturbed in the subsurface 
volume, resulting in a more asymmetric surface temperature distribution. 
 
Figure 3.12 Determination of criterion for overheated subsurface lesions: Maximum displacement of 
spatial peak temperature location dmax from subsurface HIFU ablation experiments for non-ablative, 
normal lesion, and overheated lesion cases. The level of statistical significance compared with the 
overheated lesion cases is represented by double asterisk (**) if p < 0.01. A threshold of 0.29 mm 




3.3.4 Thermal probing: temperature distribution with and without HIFU lesions 
Control images of temperature rise on the tissue surface generated by the lower 
intensity, non-ablative FUS exposure before any lesion generation are shown in Figs. 3.13A 
and 3.14A. A maximum temperature rise of 5.33°C was generated in both specimens. The 
images of temperature increase induced by the probing exposure after lesion formation in 
tissue (Figs. 3.13B and 3.14B) showed a higher temperature rise than the control case, with a 
maximum temperature rise of 8.70°C in Specimen 1 and 10.07°C in Specimen 2 (Figs. 3.13D 
and 3.14D). The difference in the temperature increase before and after lesion generation is 
shown in the subtracted images (Figs. 3.13C and 3.14C) as well as the initial heating rate 
dT/dt at the start of FUS exposures (Figs. 3.13E, 3.13F, 3.14E and 3.14F). The initial heating 
rate was dominated by the absorption before heat conduction comes into play.   
 
Figure 3.13 Thermal probing of Tissue Specimen 1 with smaller lesion volume: Images showing the 
temperature rise  ΔT(x,y,t) during (A) pre-lesion probing, (B) post-lesion probing, and (C) the 
subtraction of the two (Diff ΔT(x,y,t)= post ΔT(x,y,t)−pre ΔT(x,y,t)). (D) 1D plots of the temperature 
rise ΔT and (E) the rate of temperature change dT/dt at the center point, 0.25 mm and 0.5 mm to the 
right of the center. (F) The 2D rate of temperature change dT/dt at 0.1 s before and after lesion 





















































































































































Figure 3.14 Thermal probing of Tissue Specimen 2 with larger lesion volume. (A-G) as in Fig. 3.13. 
Lesion width = 4 mm. 
Current imaging methods where an external energy or heat source is applied to the 
target specimen to induce a temperature rise includes microwave imaging, active IR 
imaging,31 and thermal strain imaging. The introduction of an additional heat source allows 
visualization of temperature-dependent tissue properties (e.g., speed of sound), and tissue 
properties related to heat absorption (e.g., acoustic and optical absorption coefficient) and 
dissipation (e.g., thermal conductivity). Tissue coagulation caused by HIFU ablation changes 
the tissue properties including heat capacity, attenuation coefficient, sound speed, and 
thermal conductivity. The change in attenuation is the most significant, and lesions in liver, 
spleen, and abdominal wall have been found to have twice or more times the attenuation 
coefficient that of corresponding native (untreated) tissue.27,28,32 The use of non-ablative FUS 
exposures to assess tissue properties have been demonstrated with temperature measurements 
using thermocouples and ultrasound imaging.33,34 The increase in temperature rise after the 
formation of subsurface lesions was still observable from the surface temperature 
(Figs. 3.13F and 3.14F). The results were also comparable to the increase in ∂T/∂t when 
lesions formed during HIFU ablation (Section 3.3.2). In these experiments, the temperature 

















































































































































field generated by HIFU was not wide enough to cover the entire lesion. The lesion widths 
were 2.88 and 4 mm (Figs. 3.13G and 3.14G), respectively, whereas the HIFU field only had 
a –6 dB focal width of 0.9 mm. However, the extent of the increased temperature rise was 
still dependent on the lesion size. An array system for beam forming and pulse sequencing 
which provides uniform heating35 may improve and simplify interpretation of thermal 
probing results. 
3.3.5 Limitations and future study 
As seen from the current results, the use of temperature information during HIFU 
application can be complex because the irreversible changes of the thermal and acoustical 
properties of the tissue due to coagulation and the occurrence of bubble and cavity formation 
can significantly alter the normal course of temperature progression, thereby making it 
challenging to predict tissue status. While specific characteristics of the temperature 
evolution of the tissue were shown to provide useful information for monitoring HIFU 
ablation in this study, additional work will be needed to provide further improved 
unambiguous determination of specific events relevant to HIFU therapy. 
By correlating IR and bright-field images during HIFU treatments spatiotemporally, 
we were able to determine the critical CEM43 for cardiac tissue coagulation experimentally. 
However, care must be taken when applying the critical CEM43 for predicting tissue 
coagulation. Errors may arise when the value used was obtained from experiments with a 
much different temperature range or heating mechanism (e.g., heating rate, intensity). For 
example, the time required for tissue coagulation in thermal therapy (> 50 °C) may be less 
than the critical CEM43 obtained from experiments in the hyperthermia temperature range 
(40 – 45 °C).12 To make use of the simplicity of the thermal dose model and to ensure 
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prediction accuracy, a chart of applicable critical CEM43 in various different ranges of 
temperature could be further established using the same experimental set-up and processing 
method used in this study with varying HIFU intensities and exposure durations. 
In this study, cavity formation and bubble generation were determined by visual 
inspection from the bright-field images. To monitor gas bubble or cavity formation, 
especially in the subsurface HIFU experiments, passive cavitation detection techniques14,36,37 
could be incorporated in future studies. It would also be of interest to determine whether 
bubbles and cavities are formed from boiling or acoustic cavitation or the combination of 
both under current HIFU settings. 
It is possible that phenomena such as lesion formation, water dehydration and 
overheating may result in different temperature behaviors in-vivo and even for different 
tissue types. In order to provide temperature markers more relevant for in-vivo HIFU 
applications, the current study needs to be extended to experiments that consider other effects 
such as blood perfusion on HIFU ablation. Studies are also needed to more systematically 
determine the robustness and accuracy of the temperature markers for HIFU induced tissue 
coagulation and other changes. One area that could improve the current study is to implement 
better methods for detecting tissue coagulation on the surface because fast deposition of 
energy from HIFU application results in CEM43 varying significantly temporally and 
spatially, making the selection of lesion boundaries critical. For example, methods that can 






Experimental results obtained from this ex-vivo study demonstrate that parameters 
derived from the spatiotemporal changes of temperature measured at a tissue surface by real-
time IR imaging exhibit characteristic changes corresponding to lesion formation, cavity 
generation, and water extraction/tissue dehydration during HIFU ablation. The temperature-
derived parameters established in our study ( maxθ , dmax) have the potential to provide useful 
information for real-time HIFU monitoring. The study also demonstrated a method of 
determining of the critical CEM43 for cardiac tissue via spatiotemporal correlation of IR and 
bright-field images during HIFU exposure that provides results consistent with existing 
literature values. Results also demonstrate that thermal probing using lower intensity, non-
ablative FUS exposures can detect the presence of lesion using IR temperature imaging. 
The methods described herein suggest that IR imaging may be useful for direct HIFU 
monitoring where a tissue surface is accessible with a shallow HIFU focal location such as in 
breast cancer and skin cancer treatments or during open-chest/open-abdomen surgeries. The 
temperature-derived markers described in this study also have the potential serve to 
complement HIFU monitoring within a tissue volume by other methods, such as MRI, where 
direct determination of tissue status and other events is not possible in real time. As shown 
by the subsurface HIFU ablations, these temperature-derived parameters are applicable and 
useful even when direct temperature measurements of the region of interest are not feasible, 
provided the temperature information in the nearby regime is available. 





1. H. H. Pennes, "Analysis of tissue and arterial blood temperatures in the resting human 
forearm," J Appl Physiol 1(2), 93-122 (1948) 
2. W. L. Nyborg, "Solutions of the bio-heat transfer equation," Phys Med Biol 33(7), 785-
792 (1988) 
3. F. P. Curra, P. D. Mourad, V. A. Khokhlova, R. O. Cleveland and L. A. Crum, 
"Numerical simulations of heating patterns and tissue temperature response due to high-
intensity focused ultrasound," IEEE Trans Ultrason Ferroelectr Freq Control 47(4), 
1077-1089 (2000) 
4. S. A. Sapareto and W. C. Dewey, "Thermal Dose Determination in Cancer-Therapy," Int 
J Radiat Oncol 10(6), 787-800 (1984) 
5. D. Haemmerich, J. G. Webster and D. M. Mahvi, "Thermal dose versus isotherm as 
lesion boundary estimator for cardiac and hepatic radio-frequency ablation," in Proc 25th 
Annual Intl Conf IEEE Engin Med Biol Soc, 134-137, IEEE (2003) 
6. C. A. Damianou, K. Hynynen and X. B. Fan, "Evaluation of accuracy of a theoretical-
model for predicting the necrosed tissue volume during focused ultrasound surgery," 
IEEE Trans Ultrason Ferroelectr Freq Control 42(2), 182-187 (1995) 
7. S. J. Graham, L. Chen, M. Leitch, R. D. Peters, M. J. Bronskill, F. S. Foster, R. M. 
Henkelman and D. B. Plewes, "Quantifying tissue damage due to focused ultrasound 
heating observed by MRI," Magn Reson Med 41(2), 321-328 (1999) 
8. S. H. Wong, R. D. Watkins, M. Kupnik, K. B. Pauly and B. T. Khuri-Yakub, "Feasibility 
of MR-temperature mapping of ultrasonic heating from a CMUT," IEEE Trans Ultrason 
Ferroelectr Freq Control 55(4), 811-818 (2008) 
9. A. H. Chung, F. A. Jolesz and K. Hynynen, "Thermal dosimetry of a focused ultrasound 
beam in vivo by magnetic resonance imaging," Med Phys 26(9), 2017-2026 (1999) 
10. D. R. Daum, N. B. Smith, R. King and K. Hynynen, "In vivo demonstration of 
noninvasive thermal surgery of the liver and kidney using an ultrasonic phased array," 
Ultrasound Med Biol 25(7), 1087-1098 (1999) 
80 
 
11. P. S. Yarmolenko, E. J. Moon, C. Landon, A. Manzoor, D. W. Hochman, B. L. Viglianti 
and M. W. Dewhirst, "Thresholds for thermal damage to normal tissues: An update," Int 
J Hyperthermia 27(4), 320-343 (2011) 
12. X. M. He, S. Bhowmick and J. C. Bischof, "Thermal therapy in urologic systems: a 
comparison of Arrhenius and thermal isoeffective dose models in predicting 
hyperthermic injury," J Biomech Eng 131(7), 074507 (2009) 
13. V. A. Khokhlova, M. R. Bailey, J. A. Reed, B. W. Cunitz, P. J. Kaczkowski and L. A. 
Crum, "Effects of nonlinear propagation, cavitation, and boiling in lesion formation by 
high intensity focused ultrasound in a gel phantom," J Acoust Soc Am 119(3), 1834-1848 
(2006) 
14. C. C. Coussios, C. H. Farny, G. ter Haar and R. A. Roy, "Role of acoustic cavitation in 
the delivery and monitoring of cancer treatment by high-intensity focused ultrasound 
(HIFU)," Int J Hyperthermia 23(2), 105-120 (2007) 
15. F. L. Lizzi, "High-precision thermotherapy for small lesions," Eur Urol 23 Suppl 1, 23-
28 (1993) 
16. K. Ogan, W. W. Roberts, D. M. Wilhelm, L. Bonnell, D. Leiner, G. Lindberg, L. R. 
Kavoussi and J. A. Cadeddu, "Infrared thermography and thermocouple mapping of 
radiofrequency renal ablation to assess treatment adequacy and ablation margins," 
Urology 62(1), 146-151 (2003) 
17. C. Song, B. Tang, P. A. Campbell and A. Cuschieri, "Thermal spread and heat 
absorbance differences between open and laparoscopic surgeries during energized 
dissections by electrosurgical instruments," Surg Endosc 23, 2480-2487 (2009) 
18. J. A. Cadeddu, S. V. Jackman and P. G. Schulam, "Laparoscopic infrared imaging," J 
Endourol 15(1), 111-116 (2001) 
19. M. A. Groh, O. A. Binns, H. G. Burton, G. L. Champsaur, S. W. Ely and A. M. Johnson, 
"Epicardial ultrasonic ablation of atrial fibrillation during concomitant cardiac surgery is 
a valid option in patients with ischemic heart disease," Circulation 118(14), S78-S82 
(2008) 
20. S. Mitnovetski, A. A. Almeida, J. Goldstein, A. W. Pick and J. A. Smith, "Epicardial 
high-intensity focused ultrasound cardiac ablation for surgical treatment of atrial 
fibrillation," Heart Lung Circ 18(1), 28-31 (2009) 
81 
 
21. R. P. Madding, "Emissivity measurement using infrared imaging radiometric cameras," 
in Encyclopedia of optical engineering R. G. Driggers, Ed., 475-483, CRC Press, New 
York, NY (2003) 
22. W. J. Fry and R. B. Fry, "Determination of absolute sound levels and acoustic absorption 
coefficients by thermocouple probes - theory," J Acoust Soc Am 26(3), 294-310 (1954) 
23. C. E. Metz, "Basic principles of ROC analysis," Semin Nucl Med 8(4), 283-298 (1978) 
24. N. V. Chawla, K. W. Bowyer, L. O. Hall and W. P. Kegelmeyer, "SMOTE: Synthetic 
minority over-sampling technique," J Artif Intell Res 16, 321-357 (2002) 
25. J. Steketee, "Spectral emissivity of skin and pericardium," Phys Med Biol 18(5), 686-694 
(1973) 
26. D. Mitchell, C. H. Wyndham and T. Hodgson, "Emissivity and transmittance of excised 
human skin in its thermal emission wave band," J Appl Physiol 23(3), 390-394 (1967) 
27. N. L. Bush, I. Rivens, G. R. ter Haar and J. C. Bamber, "Acoustic properties of lesions 
generated with an ultrasound therapy system," Ultrasound Med Biol 19(9), 789-801 
(1993) 
28. V. Zderic, A. Keshavarzi, M. A. Andrew, S. Vaezy and R. W. Martin, "Attenuation of 
porcine tissues in vivo after high-intensity ultrasound treatment," Ultrasound Med Biol 
30(1), 61-66 (2004) 
29. R. L. Clarke and G. R. ter Haar, "Temperature rise recorded during lesion formation by 
high-intensity focused ultrasound," Ultrasound Med Biol 23(2), 299-306 (1997) 
30. C. A. Damianou, N. T. Sanghvi, F. J. Fry and R. Maass-Moreno, "Dependence of 
ultrasonic attenuation and absorption in dog soft tissues on temperature and thermal 
dose," J Acoust Soc Am 102(1), 628-634 (1997) 
31. A. Nowakowski, "Quantitative active dynamic thermal IR-imaging and thermal 
tomography in medical diagnostics," in Medical infrared imaging, N. A. Diakides and J. 
D. Bronzino, Eds., 7-1-7-29, CRC Press, New York, NY (2008) 
82 
 
32. R. L. Clarke, N. L. Bush and G. R. ter Haar, "The changes in acoustic attenuation due to 
in vitro heating," Ultrasound Med Biol 29(1), 127-135 (2003) 
33. H. Yao, R. Griffin and E. S. Ebbini, "Noninvasive localized ultrasonic measurement of 
tissue properties," in 2004 IEEE Ultrasonics Symp Proc, 724-727 (2004) 
34. D. Liu and E. S. Ebbini, "Real-time 2-D temperature imaging using ultrasound," IEEE 
Trans Biomed Eng 57(1), 12-16 (2010) 
35. T. Hall and C. Cain, "A low cost compact 512 channel therapeutic ultrasound system for 
transcutaneous ultrasound surgery," AIP Conf Proc 829, 445-449 (2006) 
36. B. A. Rabkin, V. Zderic, L. A. Crum and S. Vaezy, "Biological and physical mechanisms 
of HIFU-induced hyperecho in ultrasound images," Ultrasound Med Biol 32(11), 1721-
1729 (2006) 
37. T. D. Mast, V. A. Salgaonkar, C. Karunakaran, J. A. Besse, S. Datta and C. K. Holland, 
"Acoustic emissions during 3.1 MHz ultrasound bulk ablation in vitro," Ultrasound Med 





Dual-wavelength photoacoustic technique for monitoring tissue status 
during thermal treatments 
Photoacoustic (PA) techniques have been exploited for monitoring thermal treatments 
including high-intensity focused ultrasound (HIFU) ablations.1,2 It also allows a deeper 
imaging depth compared to infrared thermography discussed in Chapter 3. However, PA 
signals depend on not only tissue temperature but also tissue optical properties, which 
indicate tissue status (e.g., native or coagulated). The changes in temperature and tissue 
status often occur simultaneously during thermal treatments, so both effects cause changes to 
PA signals. In this chapter, we propose a new dual-wavelength PA technique to monitor 
tissue status independent of tissue temperature. Real-time HIFU monitoring was not 
performed due to limitations on our laser system, but the feasibility was demonstrated on pre-
generated HIFU lesions and real-time tissue changes was investigated through experiments 
subjected to water-bath heating. 
The work in this chapter has been published in Journal of Biomedical Optics 18(6), 
067003 (2013) entitled “Dual-wavelength photoacoustic technique for monitoring tissue 





PA effect refers to a phenomenon in which thermoelastic pressure waves (acoustic 
waves) are generated by the absorption of electromagnetic energy (e.g., optical or 
radiofrequency waves).3 PA imaging often uses short nanosecond laser pulses to excite 
megahertz ultrasound waves from optically absorbing objects, thus derives its imaging 
contrast from the optical properties of the imaged object. PA imaging has been shown to be 
capable of providing structural, functional and molecular information,3,4 and is capable of 
visualizing deeply seated tumors4,5 and showing tumor vasculature.6 Recent advances in PA 
imaging enable achievement of microscopic resolution from a few microns7 down to 
submicron.8 Its potential as a diagnostic tool is also intensively investigated.4,9 However, 
studies on the use of PA imaging for real-time monitoring of therapeutic processes are still at 
an early stage. 
A system for PA-guided HIFU ablation has its advantage by using the same 
ultrasound transducer (either a single element transducer10 or an array probe11) for both the 
HIFU treatment and PA signal detection. Estimation of tissue temperatures below 
coagulation level may be achieved from PA signal intensity.12-15 Real-time temperature 
monitoring using PA techniques has been explored during photothermal16-18 and HIFU 
treatment.1,2 Most of these studies focused on temperature measurements although tissue 
alteration during the thermal treatments, which resulted in changes in tissue optical properties, 
also contributed to the changes in PA signals. From empirical observations, a relation 
between PA signal intensity and thermal dose, instead of temperature, has been suggested as 
a better parameter for coagulation monitoring.1 In all these studies, laser excitation at a single 
wavelength in the visible or near-infrared spectrum was employed, and to estimate 
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temperature, a relation between PA signals and temperature was acquired in advance as a 
calibration.14,16  
Another suggested PA method for thermal treatment monitoring is based on the 
changes in the optical properties in thermally treated tissues. Tissues at different statuses (e.g., 
native or coagulated) have different compositions, resulting in different optical properties. 
Therefore PA signal intensity is dependent on the tissue status. In most studies, the PA signal 
intensity increased during or after coagulation, presumably as a result of the increased 
chromophore concentration due to dehydration19 and/or the formation of methemoglobin 
(MetHb), a strong optical absorber over a broad optical spectrum.19-21 Contradictory to the 
findings from most ex-vivo studies, Chitnis et al. reported a negative contrast in HIFU lesions 
in the kidney of a live rat,22 which was explained by the difference in the heating mechanism 
and the difference between in-vivo and ex-vivo conditions. However, no matter whether 
coagulated tissue exhibits a negative or positive contrast, PA signals at a single wavelength 
cannot provide a clear indication of tissue changes in real-time because the increasing 
temperature during thermal treatment also affects PA signals. 
Considering the thermal expansion of an absorbing medium heated by a short laser 
pulse with incident laser fluence F0, the PA effect can be expressed by calculating the 
pressure rise ΔP(z) in the irradiated volume under temporal pressure confinement23,24 







cP z F F z e F
C
µ µ µβ µ µ µ ′− +
 
∆ = = Γ = Γ  
 
, (4.1) 
where µa and µs′ are the optical absorption coefficient and  reduced scattering coefficient, 
respectively; z is the depth along the photoacoustic receiving beam; and Γ = βc2/Cp is the 
Grüneisen parameter with β, c, and Cp being the thermal coefficient of volume expansion, 
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speed of sound, and heat capacity at constant pressure, respectively. Γ is both temperature 
and tissue type/status dependent. When the tissue status remains unchanged, Γ is often 
empirically assumed to be linearly related to temperature.14 However, variations in the 
contents of water, lipid, proteins and other materials in different tissues yield different β, c, 
and Cp, and different dependencies of these parameters on temperature.14,25 For example, PA 
signal amplitude in lipid-rich plaques and lard decreases with temperature rise, which is 
clearly different from water-based tissues.26,27  
In order to resolve the problem of combined effects from tissue temperature and 
optical properties on PA signals during thermal treatments, we propose a dual-wavelength 
PA technique. The temperature-dependent Γ in Eq. (4.1) is removed by dividing PA signal 
intensities obtained at two different wavelengths at the same temperature. The resulting ratio 
will then depend only on the tissue optical properties, thus tissue status may be obtained 
without the effect of tissue temperature. In this study, we conducted experiments using water 
bath heating of ex-vivo porcine myocardium tissue specimens to test our proposed dual-
wavelength PA technique. Its feasibility for HIFU monitoring was demonstrated using two 
experimental groups, one with untreated tissue samples and the other with HIFU treated 




4.2 Materials and methods 
4.2.1 Theory of dual-wavelength PA technique  
In this study, we examined the simplest case where the PA signals were generated 
from locations close to tissue surface. In this case, Eq. (4.1) can be simplified into 
( ) 00 aP z Fµ∆ = = Γ . In most former studies,2,12-16,18 the temperature dependency of tissue 
optical properties was not considered because major tissue absorbers, such as hemoglobin, 
have been reported to exhibit minor changes in optical absorption (< 3.5 %) over the 
temperature range of 20 – 40 °C.28 It was also found that, in the temperature range below 
coagulation threshold, the optical absorption coefficient µa in both human skin29 and canine 
prostate30 had not much change with increased temperature. Although in these studies, 
negligible changes in optical absorption with temperature increase were observed only at low 
temperature range (up to 40 °C) since it is not feasible to measure the optical properties at 
high temperatures without inducing changes in tissue composition, we assume that the 
temperature dependency of tissue optical properties would still be negligible through the 
entire temperature range (up to temperatures above coagulation threshold). On the contrary, 
µa is highly dependent on the tissue type/status. For example, thermal induced tissue 
coagulation could lead to significant changes in µa.31-35 Therefore, in this work, µa is 
expressed as a function of laser wavelength and tissue type/status. The laser-induced pressure 
rise can now be expressed as 
 ( ) ( ) 0tissue status , temperature tissue status , wavelength aP s T s Fµ λ∆ = Γ ⋅ . (4.2) 
If we obtain PA signals using two different wavelengths, λ1 and λ2, at the same temperature 
and the same time when the tissue status is also the same, the induced pressure rise can be 
written as ( ) ( ) ( ) ( )1 1 1, , , , 0s T s T a sP Fλ λ λµ∆ = Γ and ( ) ( ) ( ) ( )2 2 2, , , , 0s T s T a sP Fλ λ λµ∆ = Γ , at the two wavelengths 
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respectively. By dividing ( )1, ,s TP λ∆  with ( )2, ,s TP λ∆ , we define a temperature independent 
parameter or ratio k as 
 ( )
( )
( ) ( ) ( )
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,  (4.3) 
where ( ) ( )1 20 0m F Fλ λ= is irrelevant to the tissue and, therefore, can be assumed constant if the 
light fluence on the sample is stable or can be normalized by monitoring the laser output 
energy. Now that the temperature-dependent Γ is eliminated from the equation, the parameter 
k depends only on the optical properties of the tissue, and should be a constant for the same 
tissue type/status under different temperatures. Because k may be different for different tissue 
types and may change when tissue alteration occurs (e.g., coagulation), it can be used to 
differentiate various tissues or as an indicator for thermal induced tissue coagulation. 
Upon examination of the pressure rise obtained at different temperatures, T0 and T1, with 
corresponding tissue statuses s0 and s1, we can write ( ) ( ) ( ) ( )0 0 0 0 0 0, , , ,s T s T a sP F λλ λµ∆ = Γ  and 
( ) ( ) ( ) ( )1 1 1 1 1, , , , 0s T s T a sP Fλ λ λµ∆ = Γ  based on Eq. (4.2). The relative signal change from T0 to T1 is 
therefore expressed as  
( ) ( )
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0 0 0 0 0 0 0 0
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If the tissue status remains the same from T0 to T1, then s1 = s0 and the relative signal change 
is simplified to ( ) ( )( ) ( )0 1 0 0 0 0, , ,s T s T s TΓ −Γ Γ  which is independent of the laser wavelength. 
Therefore we can expect the relative signal change to be the same for different wavelengths 




4.2.2 HIFU ablation and dual-wavelength PA sensing 
Ex-vivo porcine myocardium specimens obtained from the local abattoir were used in 
this study. To demonstrate the ability of dual-wavelength PA detection technique in 
monitoring tissue status without being affected by temperature change, one group of tissue 
specimens were treated with HIFU application to generate thermal lesions prior to PA 
measurement; while the other group of specimens was untreated. The HIFU system consisted 
of a HIFU transducer (2 MHz center frequency, F = 0.98, Blatek, Inc., State College, PA), a 
delay/pulse generator (Model 565, Berkeley Nucleonics Corp., San Rafael, CA), a function 
generator (33220A, Agilent, Santa Clara, CA), and a power amplifier (325LA, ENI, 
Rochester, NY) is shown in Fig. 4.1A. A tissue specimen (22 mm × 22 mm × 13 mm) was 
placed in a plastic holder with the front and the back sides covered by acoustically 
transparent membranes (Tegaderm, 3M, St. Paul, MN) to prevent possible changes in 
hydration and concentration of chromophores in the tissue specimen when submersed in 
water. Each ablation was conducted using a 20 sec pulsed HIFU exposure (1500 W/cm2 focal 
intensity, 80% DC, 10 Hz PRF) with the HIFU focus aimed near the tissue surface for visual 
confirmation of the ablation outcome. The HIFU transducer was moved using translation 





Figure 4.1 Schematic illustration of experimental set-up for (A) HIFU ablation and (B) PA sensing in 
a temperature controlled water bath. (C, D) Typical photoacoustic (PA) signal and photodiode (PD) 
signal. Vp-p denotes the peak-to-peak amplitude. 
Fig. 4.1B shows the schematic experimental setup to obtain PA signals from the 
HIFU lesions and non-treated tissues at various temperatures. The system consisted of a 
temperature-controlled water bath (Precision 280, Thermo Scientific, Waltham, MA), a 
circulating pump (Peri-Star Pro, World Precision Instruments, Inc., Sarasota, FL), a focused 
imaging transducer (10 MHz center frequency, V311, Panametrics, Waltham, MA), and a 
laser source. Tissue temperatures were controlled using the water bath and measured with a 
K-type thermocouple (0.08 mm diameter, Omega Engineering, Stamford, CT), which was 
inserted in the specimen and sampled at 20 Hz by a data acquisition system (OMB-DAQ-
3000, Omega Engineering). An Nd:YAG (Brilliant B, Quantel, Bozeman, MT) pumped 
optical parametric oscillator (OPO) system (Vibrant 532 I, Opotek Inc., Carlsbad, CA) 
provided laser pulses at 700 nm and 800 nm wavelengths with a pulse duration of 5.5 ns and 
a pulse repetition rate of 10 Hz. These two wavelengths were chosen for two main reasons: 
(1) the output energy from the laser system is strong and stable in this range; (2) the optical 
absorptions of oxygenated hemoglobin (HbO2), deoxygenated hemoglobin (Hb), and MetHb 



























































concentrations of these chromophores due to thermal coagulation. The energy of the laser 
beam was measured using a photodiode (Model 2031, New Focus, Santa Clara, CA) for later 
normalization. The PA signals received from the imaging transducer, which worked on the 
transmission mode, was first amplified by 40 dB with a pre-amplifier (5052PR, Panametrics) 
and then recorded with a 200 MHz sampling rate on a digital oscilloscope (54380B, Agilent). 
In this experiment, the temperature was only increased from room temperature to 43 °C to 
prevent any tissue alteration. For all measurements, the laser beam was centered at the lesion 
center and the beam size (3 mm in diameter) was smaller than the lesion cross section. PA 
signals were acquired for 10 sec at each wavelength at each temperature. Gross photos of the 
tissue specimens were taken after the experiment. 
4.2.3 PA spectrum 
The PA spectra of the native tissue and HIFU lesions were obtained using the same 
set-up in Fig. 4.1B. The OPO system was tunable between 680 nm to 950 nm. PA spectrum 
measurement was performed twice on each specimen: one was a native (untreated) tissue 
specimen and the other was a tissue specimen with pre-generated HIFU lesions. PA signals 
were acquired from 680 nm to 950 nm with a 5 nm step size and for 5 sec at each 
wavelength. The energy of the laser beam was also measured using the photodiode for later 
normalization. All measurements were performed with the tissue specimen immersed in 




4.2.4 Thermal treatments using water bath heating 
To investigate the changes in signal ratio k during thermal treatments, PA sensing was 
performed on tissue specimens undergoing water bath heating using the same set-up in 
Fig. 4.1B. The temperature of the water tank was gradually increased from 35 °C to 60 °C, a 
range to ensure that tissue coagulation occurred during treatment. The heating rate was 
0.20 ± 0.03 °C/min from 43 °C to 54 °C and 0.06 ± 0.02 °C/min from 54 °C to 60 °C. The 
circulating temperature-controlled system required a longer time to raise water temperature at 
higher temperatures, resulting in the slower heating rate above 54 °C. At each 
temperature/time measurement point, PA signals were acquired first at 700 nm and then at 
800 nm.  
4.2.5 Data processing 
The normalized PA amplitude was obtained by dividing the peak-to-peak PA signal 
amplitude (Fig. 4.1C) by the peak amplitude of the photodiode signal (Fig. 4.1D) to minimize 
the effect due to the fluctuation of the laser energy over time. The measured PA signals were 
averaged over 10 sec to improve signal-to-noise ratio (SNR). We denote the averaged 
normalized PA amplitude as P. The ratio k (which may differ from the k in Eq. (4.3) by some 
constant) was computed using  
 700 nm 800 nmk P P= , (4.5) 
where P700 nm and P800 nm are the measurements obtained at laser wavelengths of 700 nm and 




To investigate how PA signals depend on temperature and to compare between 
different wavelengths, the relative signal change (%) of P over temperature was computed 














= × , (4.6) 
where λ is 700 nm or 800 nm, and T0 is the reference temperature. 
4.3 Results 
4.3.1 PA spectra of native tissue and HIFU lesion 
The PA spectra acquired from the native tissue (Fig. 4.2A) and HIFU lesions 
(Fig. 4.2B) are plotted using the averaged normalized PA amplitude P (averaged over 5 sec). 
The ratio of P between the HIFU lesions and native tissue (Fig. 4.2D) was calculated by first 
averaging P from the two measurements (solid red lines in Figs. 4.2A and 4.2B) and then 
taking their ratio. The PA spectrum of the HIFU lesion has a larger signal intensity compared 
to that of native tissue across the wavelengths investigated, with the largest increase at the 





Figure 4.2 Spectrum of averaged normalized PA amplitude P at 680 – 950 nm wavelengths in (A) 
native tissue and (B) HIFU lesions. The solid red lines are the average from Measurement 1 and 2. (C) 
Extinction coefficient spectrum of deoxygenated hemoglobin (Hb) and oxygenated hemoglobin 
(HbO2). Adapted from38 D. Delpy and M. Cope, "Quantification in tissue near-infrared 
spectroscopy," Philos Trans R Soc B, 352(1354), 649-659(1997). (D) Ratio = PHIFU lesion/Pnative tissue. 
4.3.2 Ratio k is temperature-independent 
As an example, Fig. 4.3A shows the gross photo of a HIFU lesion on the surface of a 
tissue specimen. As shown in Figs. 4.3B and 4.3C, the mean ± standard deviation (S.D.) of 
the relative signal change (%) of the averaged normalized PA amplitude P in the native (no 
coagulated lesion) tissues (N = 9) and in the HIFU lesions (N = 8) computed using Eq. (4.6) 
exhibits the same trend for both wavelengths used in the experiments. Since the temperature 
range was kept below 43 °C, and measurements were made within two hours for each sample, 
no tissue alteration occurred as observed from the gross photo and calculated using the 
thermal damage model.39-41 Thus these results confirmed that the relative percentage change 
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in the PA signal intensity is independent of the wavelength at any temperature when the 
tissue properties remain unchanged. Therefore the ratio k between these two wavelengths is 
expected to be constant at different temperatures, as demonstrated in Fig. 4.4, where 
k = P700 nm/P800 nm is constant from 25 to 43 °C. Combining all data obtained from individual 
specimens and at ten different temperatures, k = 2.28 ± 0.20 in native tissues (N = 90) and 
2.70 ± 0.18 in HIFU lesions (N = 80). The difference in the k value between these two groups 
is statistically significant (p-value < 0.001). The threshold for differentiating the two groups 
is k = 2.52, as determined using the receiver-operating characteristic (ROC) curve,42 
providing an 85.3 % accuracy with an area under curve (AUC) of 0.93. 
 
Figure 4.3 (A) Gross photo of a tissue specimen with a HIFU lesion generated before PA experiment. 
(B, C) The relative signal change (%) of the averaged normalized PA amplitude P in native tissues 
and in HIFU Lesions. T0 = 25.3 ± 0.3 °C. 




















































Figure 4.4 Comparison of the dual-wavelength ratio k (700 nm/800 nm) in HIFU lesions and native 
tissues as a function of temperature. 
4.3.2 Ratio k increases with tissue changes during thermal treatment 
The averaged normalized PA signal P at 700 nm and 800 nm from one tissue 
specimen subjected to water bath heating are shown in Figs. 4.5A and 4.5B to illustrate the 
change of PA signals with increasing temperature. Both of the PA signal amplitudes obtained 
with 700 nm and 800 nm laser excitations increased with increasing tissue temperature, with 
a relatively slower increase below 50 °C and a much faster increase when temperature 
increased further. However, from either of these single wavelength results, it is difficult to 
determine when exactly coagulation or changes in tissue status/content occurred, as both 
increased temperature and tissue alteration caused the PA signals to increase in amplitude.  
By taking the ratio of the PA signals from the two wavelengths to eliminate the effect 
of temperature in the PA signals, the change in tissue status can be better identified as shown 
in Fig. 4.5C. Unlike P which is temperature dependent, k is nearly constant with increasing 
temperature until a sharp increase appeared at 56 °C, which allows clear identification of the 
temperature at which changes in tissue occurred.  
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Fig. 4.6A shows the mean ± S.D. of ratio k from five independent measurements. 
Again, it can be seen that k is nearly constant before it increases sharply at 55 °C, suggesting 
changes in the optical properties of the tissues during the coagulation process occurred at this 
temperature. Coagulation of the tissue samples was confirmed at the end of each experiment. 
Coagulated tissue appeared pinkish and white in contrast to its original dark red color. 
Individual curves of k for all five specimens are shown in Fig. 4.6B. k in each experiment 
follows a similar trend exhibiting a constant value before it increases sharply at a temperature 
between 55 to 58 °C.  
 
Figure 4.5 An example of coagulation during water bath heating: (A, B) The averaged normalized 
PA amplitude P as a function of temperature at 700 nm and 800 nm wavelengths. (C) Corresponding 
dual-wavelength ratio k (700 nm/800 nm). 
 
 
Figure 4.6 Dual-wavelength ratio k (700 nm/800 nm) during the coagulation process: (A) 
Mean ± S.D. (N = 5) and (B) individual plots as a function of temperature (°C). 
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In two sets of measurements, the coagulated tissues were allowed to cool down using 
the temperature-controlled water bath and k values were obtained in the coagulated tissues at 
a lower temperature range of 37 – 44 °C. Our experiments confirmed that k remained 
constant in this temperature range, similarly as the native tissue samples, except that 
k = 5.00 ± 0.27 in the coagulated tissues (N = 19), which is statistically significantly different 
from their native state when k = 2.55 ± 0.13 (N = 14) with a p-value < 0.001, indicating that 
the tissue status alone affects the values of k.  
4.4 Discussion 
4.4.1 Temperature dependence of PA signals 
In both experiments when tissue temperature increased with and without generating 
tissue alterations (Figs. 4.3B. 4.3C, 4.5A, 4.5B), the averaged normalized PA amplitude P 
increased as reported in previous studies.1,27,43 The relative signal change (%) in the two 
tissue types (i.e., with and without HIFU lesion) changes linearly with temperature (in the 
range of 25 – 43 °C, without inducing tissue changes) for both wavelengths used, but with a 
different percentage change under the same temperature increment (Figs. 4.3B and 4.3C). 
The reason that HIFU lesions have a smaller averaged relative percentage change is likely 
due to lesser water content in the coagulated tissue compared to non-treated tissues, and β 
and c of water have higher and positive dependency on temperature.25 The large S.D. in the 
relative signal change in both tissue types may be attributed to the variations in tissue 





For temperature estimation with PA sensing using a single laser wavelength, a 
calibration curve determining the relation between PA signal amplitude and temperature is 
usually required for a specific tissue type. This can be tedious and prone to error, as there are 
variations in the tissue composition or the proportion of each component from sample to 
sample. Inaccurate temperature estimations for thermal treatment monitoring can occur if a 
general calibration curve is used. In comparison, dual-wavelength PA sensing can directly 
monitor the tissue status change during thermal treatment process, as the ratio k remains 
constant even with increasing temperature until a marked increase occurs due to tissue 
coagulation. No calibration on the signal-temperature relationship is needed beforehand. In 
addition, the distinct k values for native tissues and HIFU lesions can be used for tissue 
characterization to detect HIFU lesions. 
It is noticed that k is smaller in HIFU lesions (Fig. 4.4) measured in our experiments 
compared to tissue samples coagulated by water bath heating (Fig. 4.6). The differences 
between the two heating processes (HIFU is fast and localized while water bath heating is 
slow and global) may lead to different tissue compositions in the coagulated tissues. Another 
possible reason for the higher k in tissues subjected to water bath heating is the much larger 
coagulated tissue volume as the coagulation occurred in the entire tissue specimen, unlike the 
HIFU lesions which were of much smaller dimensions (lesion depth ~0.5 mm). Also, ratio k 
of the water bath heated tissue appeared to continue to increase at the end of the heating 
period, suggesting that further coagulation was possible if longer and/or higher temperature 




4.4.2 Changes in optical properties of coagulated tissue 
The PA spectrum acquired in native tissue (Fig. 4.2A) exhibits a similar trend as the 
extinction spectrum of Hb (Fig. 4.2C). Since ex-vivo specimens were used in our 
experiments, the deoxygenation of blood which occurs immediately after the animals are 
sacrificed44,45 is likely to result in Hb being the main contributor to the acquired PA signals. 
To choose the best wavelengths for maximum contrast or sensitivity to monitor tissue 
changes during thermal treatment, a complete spectrum over a broad range of wavelengths 
should be investigated to determine the absorption spectrum of each tissue statuses. Although 
we measured the PA spectrum of the native tissue (Fig. 4.2A) and HIFU lesions (Fig. 4.2B) 
from 680 nm to 950 nm, measurements up to or higher than 1100 nm where water absorption 
of light becomes significant may provide additional insight to the role of water content 
during the tissue coagulation process. Nilsson et al.46 showed the absorption spectra for rat 
liver in the native state and laser induced coagulated state, where µa in general increased after 
laser treatment for the wavelengths investigated (600 – 1050 nm) with a slightly higher 
increase at 700 nm compared to 800 nm. Ritz et al.47 (400 – 2400 nm) also showed that 
porcine liver with water bath heating exhibited an increase in µa, more at 700 nm compared 
to 800 nm. These results are compatible with our PA spectrum measurements (Fig. 4.2D) and 
also the thermal heating results where the ratio (700 nm/800 nm) was greater after 
coagulation. Since the major chromophores at 700 nm and 800 nm are HbO2, Hb, and 
MetHb, the change in ratio k due to thermal heating most likely came from changes in 
proportions of hemoglobin components at high temperatures. Ideally, if we can obtain the 
complete spectrum over a wide range of laser wavelengths during thermal treatments in real-
time, any slight changes in tissue composition can be detected due to the unique absorption 
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and scattering spectrum from each component. However this may require a long acquisition 
time and, hence, may not facilitate treatment monitoring in a real-time manner. Even without 
the complete spectrum, we have shown here that two wavelengths are already sufficient to 
make distinctions between two different tissue statuses. Measurement at a wavelength with 
stronger water absorption may be used in the future to provide larger contrast showing 
dehydration as a result of thermal treatment. 
4.4.3 Limitations and future study  
For simplicity and to demonstrate the proof of concept, in this study, the PA signals 
from locations close to the tissue surface were investigated. The monitoring technique can be 
extended to the subsurface volume under one condition. If we rewrite Eq. (4.1) here:  
( ) ( )3 0a a s
z
aP z e F
µ µ µµ ′− +∆ = Γ , the exponential term indicates the decay in laser fluence as light 
gets absorbed and scattered in the subsurface volume. If the tissue status/properties between 
the surface and the target sensing/imaging depth z remain unchanged over the treatment 
period, then the exponential term stays constant and the PA signal can be expressed by 
( ) aP z Fµ∆ = Γ , where ( )
3
0
a a szF e Fµ µ µ′− += . The ratio k can then be determined similar to 
Eq. (4.3). However, if the tissue status between the surface and z changes (e.g., looking at a 
depth beneath a HIFU lesion), then the exponential term is no longer constant and the laser 
fluence at z cannot be monitored or normalized. In other words, the dual-wavelength PA 
technique has the ability to monitor lesion boundaries in the subsurface volume, but not the 




Water-bath heating was applied in this study to raise temperature and a uniform 
temperature distribution was generated inside the tissue specimen. For future studies, it is 
important to investigate the changes in the shape and intensity of PA signal due to a non-
uniform temperature distribution generated during HIFU ablation. It is likely that an imaging 
ultrasound probe is needed otherwise the shape of the PA signal obtained using a single 
element transducer may change, and data processing methods other than taking the peak-to-
peak voltage may be required. 
The limited speed of wavelength tuning of the OPO system used in this study does 
not allow implementation of real-time monitoring of HIFU ablation with the dual-wavelength 
PA sensing technique. For future exploration, integrating the HIFU system with PA 
sensing/imaging in real-time is important. We have performed initial tests using two laser 
systems, each operating at one wavelength. Details are described in Sec. 5.1.  
4.5 Conclusions 
We demonstrated the feasibility of a dual-wavelength PA sensing technique to detect 
changes in tissue optical properties due to thermal treatment. Unlike single wavelength PA 
methods, our technique uses the temperature-independent ratio of the PA signals obtained at 
two laser wavelengths. Our method can be used to monitor tissue changes during thermal 
treatment without the need for a calibrated relation of PA signals and temperature in advance. 
Our results suggest that the technique may have the potential for monitoring thermal 
treatments such as those based on photothermal, radiofrequency, and HIFU ablations. 
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Conclusions and future work 
Focused ultrasound (FUS) is a promising modality for non-invasive, targeted 
hyperthermia and HIFU ablation.1-3 However, FUS-compatible guiding and monitoring 
systems to provide real-time measurement on temperature and tissue status are limited to 
ultrasound and magnetic resonance imaging (MRI). The work described in this dissertation 
represents efforts to develop new tools to boost the current research on ultrasound 
thermometry and to investigate new imaging modalities to improve controlled HIFU ablation 
based on infrared (IR) thermography and photoacoustic (PA) imaging.  
This dissertation research contributed to the field of ultrasound thermometry by 
introducing IR thermography as a new independent temperature measurement tool to 
calibrate tissue-specific properties and to validate temperature estimation in a fast manner 
with high spatial information unavailable in previous studies (Chapter 2). In Chapter 3 we 
further utilized IR thermography to monitor lesion formation and bubble activities that 
occurred close to the tissue surface. The spatiotemporal temperature characteristics 
determined in correspondence to HIFU events are applicable to HIFU monitoring using 
alternative temperature measuring techniques. The presented experimental design using 
simultaneous bright-field imaging and IR imaging is advantageous for determining tissue-
specific thermal damage threshold, which is a critical indicator of successful treatment 
outcome for various types of thermal therapy. Finally, an innovative PA imaging technique 
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to monitor tissue status independent of temperature by utilizing laser illuminations at two 
wavelengths was proposed (Chapter 4). The method can be extended to multiple wavelengths, 
with the choice of wavelengths dependent on the absorption spectrum of the target object. 
The temperature-independent parameter can be applied in monitoring thermal therapy 
including but not limited to HIFU ablation, photothermal treatment, and radiofrequency 
ablation. When the technique is further utilized for tissue characterization in diagnostic 
settings, by eliminating factors due to variations in patient body temperature and 
environment temperature, it may improve diagnosis accuracy compared to single wavelength 
PA imaging techniques. 
For the techniques presented in this dissertation to become more clinical relevant, 
they have to be further demonstrated in-vivo where effects such as blood perfusion during 
FUS heating need to be considered. Laparoscopic IR probes4 can be used for the second 
study, and PA endoscopes with integrated optical fibers for light delivery5 can be used for the 
third study.  
Other future studies which we would like to investigate include 1) real-time HIFU 
ablation monitoring using dual-wavelength PA imaging, 2) tissue characterization using non-
ablative FUS-modulated active dynamic IR thermography, and 3) tissue characterization 
using non-ablative FUS-modulated PA imaging. The rationale and preliminary results are 




5.1 Real-time HIFU ablation monitoring using dual-wavelength PA imaging 
As mentioned in Sec. 4.4.3, for real-time HIFU monitoring, we have integrated two 
laser systems by adding another Nd:YAG laser system (Powerlite DLS 8010, Continuum, 
Santa Clara, CA) operating at 1064 nm to the original set-up (Fig. 5.1). The choice of 
1064 nm is because of water being more absorptive of light at this wavelength6 and the 
resulting ratio k may provide a better contrast when tissue coagulates, which is generally 
accompanied by dehydration. The OPO laser operates at a wavelength tunable from 680 to 
950 nm, and a dichroic mirror (50% transmittance/reflectance at 900 nm) is used to allow the 
light beam to propagate into the same direction into the tissue specimen. Synchronization 
between the two laser systems and HIFU system is achieved using the delay/pulser, with 
pulse sequences shown in Fig. 5.2. 
 
Figure 5.1 Schematic of the real-time dual-wavelength PA sensing during HIFU application using 
two laser sources. 
Nd:YAG OPO laser






























Figure 5.2 Time sequence interleaving HIFU exposures and PA imaging pulses with laser 
wavelength λ1 = 1064 nm and λ2 = tunable 680 – 950 nm. 
5.1.1 Preliminary results 
Fig. 5.3A shows an example of the normalized PA amplitude Ᵽ (calculated by 
dividing the peak-to-peak PA signal amplitude by the peak amplitude of the photodiode 
signal) at 700 nm and 1064 nm before, during, and after a 30 sec HIFU exposure (2 MHz 
center frequency, 1500 W/cm2 focal intensity, 80% DC, 10 Hz PRF). No observable lesion 
was formed on the tissue surface. Although the ratio between the normalized PA amplitude 
obtained at the two wavelengths (1064 nm/700 nm, Fig. 5.3B) stayed almost constant over 
time, it exhibited undesired large standard deviation (S.D.) which defeats its purpose for 
accurate monitoring of changes in tissue status. Moreover, in cases where HIFU lesions were 
generated, the acoustic transparent wrap used for preventing changes in hydration and 
concentration of chromophores in the tissue specimen was also heated and damaged, making 
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Figure 5.3 (A) Normalized PA amplitude Ᵽ with laser illuminations at 700 nm and 1064 nm before, 
during, and after a 30 sec HIFU exposure. (B) Corresponding ratio (1064 nm/700 nm). 
  
For further studies of real-time HIFU monitoring using the dual-wavelength PA 
technique, it is important to have alternative set-up designs and/or more advanced signal 
processing methods to achieve higher signal-to-noise ratio (SNR) and a smaller signal S.D. 
Short time averaging or filtering may be used without slowing the ablation process. The 
overheating of the wrap also needs to be avoided. Moreover, since light beam is scattered and 
absorbed as it penetrates into the tissue, the feasibility of applying the same technique for 
monitoring HIFU ablation aimed at the tissue subsurface volume needs to be further 
investigated. Composite parameters combining temperature and tissue status will be 
investigated to further improve sensitivity and specificity. For the technique to become more 
widely adopted in the long term, advancement in new laser systems capable of fast 
wavelength tuning at lower cost is critical. 













































5.2 Tissue characterization using non-ablative FUS-modulated active dynamic IR 
thermography 
Most clinical applications of IR thermography use only passive temperature 
measurements. However the use of an external heat source to induce thermal response inside 
tissue has received more attention over the past few years.7 These kinds of “active dynamic 
IR imaging” are less sensitive to external conditions such as ambient temperature and 
provide visualization on subsurface abnormalities. When subjected to the same heat source, 
different tissue types may exhibit different transient temperature responses, which can be 
utilized for tissue characterization. Microwave radiation and halogen lamp are commonly 
used heat sources for active dynamic IR imaging. For example, IR temperature 
measurements with the use of halogen lamp to heat up skin have been investigated for 
differentiating burn wounds with varying burn depths.8 However, to better visualize 
subsurface abnormalities, our hypothesis is to instead use FUS to noninvasively generate a 
heat source in the subsurface volume. Since FUS is only applied to induce transient 
temperature changes and not cause tissue damage, acoustic intensity needs to be in the non-
ablative range. 
Although for different tissue compositions or tissue types, the IR measured surface 
temperature evolution may already be different (as demonstrated in Sec. 3.3.4 for HIFU 
lesions and normal tissue), it is more valuable if the 3D spatiotemporal temperature 
information in the subsurface volume can be further reconstructed. In our collaboration 
work,9 the 3D acoustic and thermal properties as well as temperature evolution within a 
subsurface tissue volume was reconstructed based on the spatiotemporal IR temperature 
measurements. However the algorithm used was computationally intensive. Therefore, we 
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propose to use another inverse bio-heat transfer method to reconstruct the tomographic 
temperature distribution without first reconstructing the acoustic and thermal properties. The 
method will use multiple control points to compute the 3D heat source generated by FUS 
exposures with the assumption of axial symmetry along the FUS propagation path. These 
control points distribute over various depths and distances from the FUS focus. The 3D heat 
source is optimized by minimizing an objective function f(TIR−TC), where TIR is the IR-
measured temperature and TC is the corresponding set of calculated temperature. The 3D 
temperature distribution is then calculated based on the 3D heat source and will be verified 
with temperature measured by thermocouples inserted in the subsurface.  
A Potential model for FUS-modulated active dynamic IR imaging is breast cancer. 
The differences in ultrasound absorption and thermal conduction between breast tumor and 
normal breast tissue can result in a different temperature transient under the same FUS 
exposure. However, for 3D inverse reconstruction of temperature, the inhomogeneity in 
breast tissue may introduce reconstruction errors and needs to be carefully examined. 
5.3 Tissue characterization using non-ablative FUS-modulated PA imaging 
Based on the results from this dissertation and using a similar concept as in Sec. 5.2, 
we discover a potential imaging modality with a newly defined tissue contrast, which 
combines the optical, acoustic, and thermal properties of tissue. It was shown in Chapter 4 
that below tissue coagulation threshold, the relative percentage change in PA signal intensity 
under a certain temperature change depends on the tissue type. The reason behind such 
phenomenon is because the thermal expansion coefficient and speed of sound of tissue 
depend on its composition and are often temperature dependent. For example, HIFU lesions 
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had a smaller averaged relative percentage change compared to that of native tissue under the 
same temperature increment (Section 4.3.2 and Fig. 4.3) likely due to their having a lesser 
water content. The phenomenon was also observed in Chapter 2 where water-based and oil-
based phantoms exhibited different echo time shifts under the same temperature rise.  The 
concept can therefore be brought into tissue characterization using PA imaging with 
temperature elevation provided from an external heat source. The changes in PA signal due 
to temperature changes can be different in different tissue types, providing contrasts 
unavailable at a fixed temperature. A similar concept was proposed by Wang and 
Emelianov10 to distinguish periadventitial fat and lipid-rich atherosclerotic plaques, which 
were undistinguishable using spectroscopic PA methods. However their experiment was 
performed in water bath and warm saline and cold ice were used to adjust the temperature, 
which are not practical and feasible in clinical use. To generate temperature transient non-
invasively, FUS again is the ideal candidate. 
The potential of lower intensity, non-ablative FUS heating to generate temperature 
transient as a diagnostic or post-treatment assessment tool was also studied in Section 3.3.4 
using IR thermography. Under the same FUS transducer settings, the higher acoustic 
absorption in HIFU lesions led to the higher temperature rise compared to that of native 
tissue (Fig. 3.13 and Fig. 3.14). Therefore by combing non-ablative FUS exposures with PA 
imaging, a new tissue contrast is developed based on the combined differences in the optical, 
acoustical, and thermal properties in different tissue types. 
5.3.1 Theory: FUS-modulated PA tissue contrast 
Assume PA signals are collected for two tissue types/statuses s1 and s2 at their 
baseline temperature T0 and their individual FUS-elevated temperature of T1 and T2, where T1 
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and T2 depend on their acoustical and thermal properties. Using Eq. (4.2) at one single laser 
wavelength: , , 0s T s T sP Fα∆ = Γ , we have the pressure rises summarized in Table 5.1. The tissue 
contrast, defined as the ratio between the PA signal intensity after FUS heating and before 
FUS heating, now only depends on the Grüneisen parameter Γ, and not the optical properties. 
Table 5.1 Tissue contrast from PA imaging with FUS-induced temperature modulation.  
 Tissue s1 Tissue s2 
Before FUS exposure 
(Baseline Temp. T0) 1 0 1 0 1, , 0s T s T s
P Fα∆ = Γ  
2 0 2 0 2, , 0s T s T s
P Fα∆ = Γ  
After FUS exposure 
(Temp. T1) 
1 1 1 1 1, , 0s T s T s
P Fα∆ = Γ  
(Temp. T2) 
2 2 2 2 2, , 0s T s T s
P Fα∆ = Γ  
Tissue contrast 


















5.3.2 Potential models  
Considering the technique does not detect one particular tissue property, but rather 
the combined effect from the acoustical (FUS heating), optical (PA imaging), and thermal 
(FUS heating) properties, we propose the following prominent models for future exploration: 
fatty liver, tumor, osteoporosis etc. The method should be most promising in distinguishing 
fat-based and water-based tissues due to the Γ of fat is inversely proportional to temperature 
whereas Γ of water is proportional to temperature. The resulting tissue contrasts will 
therefore be negative in fat and positive in water in the extreme. 
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Theory of infrared radiation 
All objects with a temperature > 0 K radiate energy. The relation between total 
radiation power W (watt) and temperature T (K) of a blackbody can be expressed by the 
Stefan-Boltzmann law1 
 4W A Tσ= ⋅ ⋅ , (6.1) 
where the radiated power is from a body of area A (m2) and σ is the Stefan-Boltzmann 
constant = 5.67×10-8 (W∙m-2∙T-4). Unlike Stefan-Boltzmann law which integrates the 
radiation over the entire spectrum, infrared (IR) cameras operate in a specific range of 
wavelengths and use a different relation between received radiation power and temperature. 
Conversion from IR radiance to temperature is usually performed using the manufacturer’s 
calibration and non-uniformity corrections. For derivation purposes, we denote W simply as a 
function of T: W(T). The temperature of the object of interest Tobj measured using IR 
thermography can therefore be calculated from Wobj, the radiation power from the object if it 
were a black body. The total received radiation power Wtot from the IR camera is expressed 
as2 
 ( ) ( )1 1tot obj amb atmW W W Wε τ ε τ τ= ⋅ ⋅ + − ⋅ ⋅ + − ⋅ , (6.2) 
where ε is the emissivity of the object, τ is the transmittance of the atmosphere, and Wamb and 
Watm are the radiation power from ambient sources and the atmosphere. With air atmosphere, 
τ can be assumed to be 1 (100% trasmittance) and Eq. (6.2) can be simplified to 
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 ( )1tot obj ambW W Wε ε= ⋅ + − ⋅ . (6.3) 
For precise temperature conversion from Wobj, ε and Wamb have to be accurately provided. 
A.1 Ambient temperature 
Wamb can be determined if the ambient temperature is given. When the object is at 
room temperature Tobj = Tamb, we can assume Wobj = Wamb = W. Substituting Eq. (6.3) gives us 
 ( )1totW W W Wε ε= ⋅ + − ⋅ = , (6.4) 
where ε does not affect the total radiance and Wamb simply equals Wtot. This simple method 
should be used immediately before each experiment with the target object left at room 
temperature for sufficient long period of time to ensure temperature equilibrium. 
A.2 Emissivity 
 As seen in Eq. (6.3), accurate input of ε is also important for temperature conversion, 








Note that emissivity measurement cannot be performed with the object at ambient 
temperature (Wobj = Wamb). To estimate the temperature measurement error due to inaccurate 
input emissivity εinput, let εinput = εtrue + dε, where εtrue is the true emissivity and dε is the error, 
and object radiation power Wobj = Wamb + dW, where dW is the radiation power difference 
between the object and the ambient temperature. The error of between calculated object 
radiation power Wcal and true radiation power Wtrue can then be derived from Eq. (6.3): 
 ( ) ( )1tot input amb input amb input ambW W dW W dW Wε ε ε= ⋅ + + − ⋅ = ⋅ +  (6.6) 
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 tot amb tot amb
input true









tot ambtot amb tot amb
error cal true
true true true true
d W WW W W WW W W
d d
ε
ε ε ε ε ε ε
− ⋅ −− −
= − = − =
+ ⋅ +
 (6.8) 
Note that when εtrue is smaller, Werror is larger. Therefore care must be taken especially when 
imaging objects with small ε value. 
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